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Abstract 
 
 
Amphetamines (AMPH) are relatively unique amongst the category of 
psychoactive drugs, as they are both prescribed for therapeutic purposes at an 
alarmingly increasing rate and abused illicitly on account of their potential pleasurable 
effects (World Drug Report, 2012).  In adult subjects, chronic AMPH use is associated 
with deficits in decision-making (i.e., impulsivity) and working memory (e.g., Bechara et 
al., 1994; McKetin and Mattick, 1998; Rogers et al., 1999; Ornstein et al., 2000).  
However, not as much research exists about adolescent drug exposure and the long-
lasting consequences on cognitive function in adulthood.  We hypothesize that drug-
induced changes in brain function are a major contributing factor to the behaviors that 
characterize addiction.  In addition, drug exposure during a maturational time, such as 
adolescence, could have delayed and harmful consequences well after treatment has 
ceased.  Thus, a major goal of this thesis was to examine the enduring effects of 
repeated AMPH exposure on cortical function and cognitive behavior.     
The experiments presented here were designed using methods very sensitive to 
prefrontal cortex (PFC) function.  In experiment 1 (Chapter 5), single-unit recordings 
from actively behaving rats were used to examine the relationship between the 
locomotor response (i.e., the ability to induce sensitization) and medial PFC (mPFC) 
firing activity to repeated AMPH treatment.  The results suggested that repeated AMPH 
led to very selective changes in mPFC function when behavioral sensitization was 
present.  Specifically, the magnitude of excitatory responses increased with the 
development of sensitization but was less persistent with a maximal sensitized 
response.  In experiment 2 (Chapter 2), the relationship between behavioral 
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sensitization and impulsive choice behavior (operant delay-discounting) was examined 
in rats that received prior, repeated AMPH treatment.  Chronic exposure to AMPH did 
not cause rats to become more impulsive.  However, long-lasting changes in AMPH-
induced locomotor activity were observed.  The results suggested that the 
neuroadaptations associated with behavioral sensitization did not cause enduring 
deficits in the aspects of cognition that the delay-discounting task requires.  In 
experiment 3 (Chapter 3), we examined whether impulsivity might be a pre-existing trait 
by using an established model that is based on an initial drug response to a low dose of 
cocaine.  The results suggested that differential sensitivity to cocaine-induced 
locomotion was predictive of impulsivity, and the potential differences could shed light 
into mechanisms contributing to the vulnerability for addiction.   
In experiment 4 (Chapter 4), we took a multi-faceted approach to examine long-
lasting consequences of chronic AMPH exposure on working memory function.  We had 
three main factors in mind: method of drug exposure (repeated, intermittent versus 
escalation-binge), age of drug exposure (adolescence versus adulthood), and the initial 
sensitivity of a psychostimulant.  While adolescent-treated rats were found to be less 
sensitive to the stereotypy-inducing effects of both the intermittent and escalation-binge 
methods than adult-treated rats, they were more vulnerable to exposure-induced 
learning and memory impairments as tested in adulthood.  Interestingly, the age-related 
deficits agree with the equal, but opposite model of drug action.  That is, the intermittent 
regimen impaired working memory in adolescent-treated and not adult-treated rats, 
whereas the escalation-binge regimen impaired working memory in adult-treated and 
not adolescent-treated rats.  In addition, the delay dependent deficits in adolescent- and 
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adult-exposed rats were predicted based on their initial sensitivity to a single injection of 
cocaine.  
In the experiments presented here, repeated exposure to AMPH was found to 
have long-lasting consequences on learning and memory processes.  These deficits 
were associated with initial differences in cocaine-induced locomotor activity.  Moreover, 
the deficits were dependent on both the age and method of drug exposure.  Taken 
together, our findings suggest that particular populations of neurons are more 
vulnerable to AMPH-induced changes.  This notion is key in interpreting findings that 
suggest sensitizing regimens of AMPH do not necessarily lead to long-lasting changes 
in behavioral tasks that are sensitive to changes in PFC function.  Furthermore, 
focusing on pathway-specific changes, especially within a neurodevelopmental 
framework, will be key in future studies if we want to understand individual 
vulnerabilities to psychiatric disorders such as addiction. 
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To those who percolate with passion: may you inspire others with what you know, never 
be afraid to fail, and always drink great wine. 
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CHAPTER 1: GENERAL INTRODUCTION 
 
Historically, stimulants such as amphetamine (AMPH) were used to treat a 
number of medical ailments, and in particular, obesity, asthma, narcolepsy, and 
attention-deficit hyperactivity disorder (ADHD).  Today, AMPH is widely accessible, in 
large part, because of the availability and illegal distribution of prescription 
stimulants, such as Adderall and Dexedrine (both amphetamines, different isomers).  
The prevalence of illicit use varies worldwide and it has been estimated that 33 
million people have consumed amphetamines (World Drug Report, 2012), whereby 
individuals aged 12-24 report the highest rates of active use (estimated 19.5 million; 
Substance Abuse and Mental Health Services Administration, SAMHSA, 2011).  
Investigations into the motives behind illicit use in teenagers and young adults have 
revealed that most take amphetamines to enhance academic performance and 
alertness, as well as to produce euphoria (Teter et al., 2006; Judson and Langdon, 
2009).  As with other drugs of abuse, individuals can become dependent upon 
stimulant use.  In fact, initiation of drug use before age 14 leads to approximately a 
four times greater likelihood to abuse or become dependent later in life (SAMHSA, 
2006).   
 
Cortical memory systems and drug abuse in humans 
 Much of the focus on neural systems and drug abuse has been directed at 
subcortical structures, such as the striatum (e.g., Graybiel et al., 1990; Robbins and 
Everitt, 1999; Everitt and Robbins, 2013).  More recently, imaging evidence from human 
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substance abusers has strengthened a role for cortical and limbic systems as major 
structures adversely affected by chronic drug exposure.  For instance, Rogers et al. 
(1999) found that AMPH abusers exhibited deficits in a decision-making task similar to 
those exhibited by patients with focused damage to their prefrontal cortex.  Similarly, a 
study by Ornstein et al. (2000) tested subjects who were AMPH abusers on a test 
battery that examined a number of components that are sensitive to cortical damage, 
such as recognition memory, spatial working memory, planning, visual discrimination 
learning, and attentional set-shifting.  While the authors failed to find impairments in 
tasks related to verbal fluency and recognition, they found a number of deficits in a 
majority of the decision-making and working memory tasks, supporting the hypothesis 
of frontal-executive dysfunction in chronic drug abusers.  A more recent study by Ersche 
et al. (2008) showed that one form of response-reversal learning was impaired in 
chronic cocaine abusers, but not those abusing amphetamine.  Careful attention should 
be given when interpreting data to prevent broad generalizations of learning and 
memory deficits related to the chronic use of different psychostimulants (also see 
Verdejo-Garcia et al., 2005).  Furthermore, results from human studies make it rather 
difficult to ascertain whether co-morbid personality traits (e.g., excessive risk taking, 
sensation seeking, or impulsivity) and cognitive dysfunction predate the onset of drug 
use or occur as a consequence of chronic use.  Current hypotheses suggest that 
chronic drug use leads to impairments in functions mediated by the prefrontal cortex 
and associated limbic circuitry (Jentsch and Taylor, 1999; Goldstein and Volkow, 2002; 
Koob and Volkow, 2010; Kalivas and Volkow, 2012).  Thus, characterizing the extent of 
cognitive deficits associated with chronic psychostimulant exposure could provide 
 3 
insight into underlying neural mechanisms of drug abuse and dependence.  
Alternatively, such impairments may have been pre-existent and intensified by 
subsequent drug exposure.  Because the issue of causality has not been resolved in 
human studies, it is imperative that research in animal models can distinguish brain 
abnormalities that could predispose individuals to use drugs from changes that likely 
result from chronic drug abuse. 
 
Cortical memory systems and drug exposure in animals 
Preclinical (or animal) studies, including the experiments detailed here, offer the 
opportunity to distinguish hypotheses based on both predisposing factors and the 
interactions with chronic use of psychostimulants, such as AMPH.  For example, long-
term self-administration of cocaine in non-human primates has been associated with 
deficits in stimulus discrimination and delayed spatial alternation tasks that are sensitive 
to disruptions in PFC function (Liu et al., 2008).  In rats allowed extended access to 
intravenous (i.v.) cocaine, but not those allowed limited access, impairments in working 
memory were observed (George et al., 2008).  In rats exposed to 30 mg/kg cocaine for 
14 days, impairments in reversal learning (Schoenbaum et al., 2004) and reinforcer 
devaluation (Scheoenbaum and Setlow, 2005) were reported.  Deficits have also been 
reported following repeated AMPH exposure, particularly in tests of working memory 
(Castner et al., 2005), attentional set-shifting (Fletcher et al., 2005), and visual attention 
(Fletcher et al., 2007).  In contrast to these results, a number of studies did not find 
impairments in working memory (Featherstone et al., 2008), spatial learning or memory 
(Russig et al., 2003), or delayed alternation (Stefani and Moghaddam, 2002) after 
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repeated exposure.  Confounding variables that may contribute to these disparate 
findings among studies are the method of repeated drug exposure and the task 
specificities.  However, this has not been analyzed systematically within the same 
study.  Thus, a major aim of the experiments carried out here is to address how different 
drug exposure paradigms affect both locomotor and task behaviors that have varying 
levels of difficulty and more robust and thorough task components (i.e., learning and 
memory, strategy, reversal). 
 
Repeated and intermittent drug exposure method 
An influential animal model associated with repeated, intermittent administration 
of psychostimulants has been shown to induce long-lasting changes at the behavioral, 
anatomical, and neurochemical levels.  This form of plasticity is referred to as 
behavioral sensitization (Robinson and Becker, 1986), or an increased response to the 
drug, that is evident in certain species-specific behaviors.  For example, one would see 
motor hyper-responsiveness (i.e., increased locomotion and rearing) at relatively low 
doses and stereotypy, or patterns of repetitive behavior, at higher doses (Segal and 
Schuckit, 1983).  Sensitization has also been described in humans, especially in the 
context of drug-induced psychosis (Robinson and Berridge, 1993; Bartlett et al., 1997; 
Ujike and Sato, 2004) and AMPH-induced euphoria, drug “liking”, and motor activation 
(Strakowski et al., 1996, 2001; Boileau et al., 2006).  Furthermore, sensitization has 
been hypothesized to contribute to the development of compulsive behaviors that 
characterize addiction (Robinson and Berridge, 1993; Kalivas et al., 1998).  An 
extensive literature suggests that the mesolimbic DA system, which includes cell bodies 
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in the substantia nigra and ventral tegmental area (VTA) that predominately innervate 
the dorsal striatum, NAc, and PFC, is a critical component of the neural circuitry that 
underlies behavioral sensitization.   
 
Escalation and binge exposure method 
 Compared to intermittent drug exposure, the model of escalation and binge has 
been understudied in animals, even though human drug taking patterns are very 
different from those typically administered in an intermittent paradigm.  In order to 
assess human-related deficits in cognition, it is especially important to simulate human 
abuse patterns in animal models.  Humans commonly escalate doses of intake, after 
which the frequency of use increases (Gawin, 1991; Angrist, 1994; Gawin and Khalsa-
Denison, 1996), resulting in high dose binge patterns of administration.  It has been 
suggested that the previous period of escalation before binge episodes serves as a 
protectant to the neurotoxic or lethal effects associated with high acute stimulant doses 
(Seiden et al., 1975; Ricaurte et al., 1980; Fleckenstein et al., 2000; O’Dell and 
Marshall, 2000).  Thus, the development of tolerance during escalation likely impacts 
subsequent drug-induced behavioral profiles differently than an intermittent, same dose 
paradigm.  In fact, Segal and colleagues (2003) have shown that tolerance also 
develops to the stereotypy-inducing effects, which is paralleled with attenuation in the 
reduction of striatal DA content and DAT binding.  This is in contrast with studies that 
show evidence for neurotoxicity and long-term declines in DA levels and plasma 
membrane DAT and the vesicular monoamine transporter (VMAT) in rats and from 
neuroimaging studies in humans (Wilson et al., 1996; Volkow et al., 2001; Chang et al., 
 6 
2007).  While several studies have examined the effects of acute binge treatments on 
cognitive function and reported impairments in simple novel object recognition (NOR, 
Bisagno et al., 2002, 2003; Schroder et al., 2003), the escalating dose binge regimen 
has not been shown to cause impairments in that NOR task (Clark et al., 2007).  Thus, it 
appears that dose escalation prior to the binge phase alters the behavioral and 
neurochemical responses in a way that might be more protective of long-term cognitive 
function.  However, there have been no studies that have examined cognitive function 
using other tasks.            
 
Initial sensitivity to psychostimulants 
 The possibility that individual differences underlying drug vulnerability might 
reflect distinct behavioral and neurobiological traits is supported in a number of human 
and animal studies.  In humans, differences in the initial sensitivity to cocaine’s effects 
are predictive of long-term use and dependence (Davidson et al., 1993; Haertzen et al., 
1983; Schafer and Brown, 1991) and a recent study has indicated that individuals who 
reported a high degree of “liking” or “wanting” on their initial use of cocaine had a 
significantly increased risk of cocaine abuse (Lambert et al., 2006).  In rodents, a 
reliable indicator of initial sensitivity to psychostimulants is drug-induced locomotor 
activity in an open-field arena.  Cocaine, in particular (Briegleb et al., 2004) has variable 
stimulant effects on behavior, such that outbred rats can readily be classified as low or 
high cocaine responders (LCRs or HCRs, respectively) based on their response to a 
single treatment with cocaine (Sabeti et al., 2002; Gulley et al., 2003; Gulley, 2007; 
Klein and Gulley, 2009).  Interestingly, these individual differences are related to 
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differences in the function of dopamine transporters (DATs) in the dorsal striatum and 
nucleus accumbens (Sabeti et al., 2002, 2003) and not to pharmacokinetic factors 
(Gulley et al., 2003).  Subsequent studies have shown that the LCR/HCR phenotype 
can be used to predict a number of behaviors, such as conditioned place preference 
(Allen et al., 2007), intravenous cocaine self-administration (Mandt et al., 2008), and 
drug-discrimination (Klein and Gulley, 2009).  Thus, at this point, we speculate that the 
overlap between phenotypic differences and subsequent behaviors can be related to 
the vulnerability for drug dependence.  This is the basis for key experiments proposed 
here that extend these findings in relation to repeated psychostimulant exposure and 
subsequent interactions with ensuing behaviors from experimental paradigms that 
assess aspects of impulsivity and cognitive behavior.  
 
Adolescent psychostimulant exposure and age-dependent changes 
Most studies of the effects of repeated psychostimulant exposure have been 
carried out in adult subjects.  However, adolescence, which in humans generally 
includes the ages of 12-18 years old, is a period when many individuals are first 
exposed to drugs of abuse.  For some, initial use develops into long-lasting problems 
with drug abuse and addiction.  In fact, studies have revealed that the use of 
psychoactive substances increases during adolescence, with a peak reached at age 18-
20 (SAMHSA, 2011).  Given this link between adolescent-onset of drug use and 
addiction, it is important to determine how early drug exposure affects an individual’s 
susceptibility to develop drug abuse in adulthood.   
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A particularly advantageous experimental approach is to use rodent models of 
adolescence, partly because the developmental period of adolescence spans roughly 
two weeks (P35-50), rather than six or more years in humans (Spear, 2000).  This offers 
the promise of a more ready determination of causal relationships between neural 
function and behavior.  Importantly, the transition to adulthood in rodents entails many 
aspects found in human transition to adulthood, e.g., physiological maturation as well as 
ethological factors, such as departing from the early home environment and changing 
social companions.  Adolescent rats also spend a large amount of time in social 
interaction and play behavior (Panksepp, 1981) and are hyperactive in exploring novel 
environments (Spear and Brake, 1983).  The mesocorticolimbic dopamine (DA) circuitry 
is important for these behaviors, is also known to be critical for the locomotor-
stimulating and reinforcing effects of psychostimulant drugs (Wise and Bozarth, 1987; 
Koob, 1992; Bardo, 1998), and is undergoing normal changes during the adolescent 
period (see Brenhouse and Andersen, 2011). 
The underlying neuroadaptations in adolescents taking drugs are intriguing 
because the brain (and frontal cortex, in particular) is already in a state of development 
flux (see Casey et al., 2005; Brenhouse and Andersen, 2011).  On a cellular level, the 
most prominent changes include: alterations in cell number and dendritic morphology 
(Cunningham et al., 2002; Markham et al., 2007), as well as synaptic pruning, with 
substantial synapse elimination of glutamatergic input to the PFC (Huttenlocher, 1984; 
Insel et al., 1990) and increases in dopaminergic inputs to the PFC (Kalsbeek et al., 
1988; Leslie et al., 1991; Rosenberg and Lewis, 1994).  Drugs are likely to perturb this 
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process in a way that has long-lasting implications that might not become evident until 
adulthood.   
Unfortunately, we do not have a great understanding of the enduring 
consequences of early psychostimulant exposure.  Several studies have shown that 
adolescent rodents are less sensitive to the acute effects of psychostimulants compared 
to adults on tasks that measure arousal, motivation, and rewarding properties of drugs; 
such tasks include locomotor activity, conditioned place preference, and preference for 
natural rewards (Laviola et al., 1995; Carlezon et al., 2003; Bolanos et al., 2003, 
respectively).  Very few studies, though, have examined the long-term effects as 
expressed during adulthood.  A study by Brandon et al. (2001) examined the effects that 
repeated methylphenidate (Ritalin) had on cocaine self-administration in adult rats.  
They found that adolescent exposure to methylphenidate facilitated the acquisition of 
cocaine self-administration in adulthood.  Their findings suggest that those rats 
displayed an enhanced sensitivity to the rewarding properties of drugs.  Several more 
studies have recently emerged regarding the effects of early psychostimulant exposure 
on cognitive function into adulthood.  For example, deficits were found in object 
discrimination (Santucci and Rabidou, 2011) and stimulus-reward learning (Harvey et 
al., 2009) after repeated cocaine exposure, in spatial learning after repeated 
methamphetamine (Vorhees et al., 2005), and in impulse control after repeated AMPH 
(Hankosky and Gulley, 2012) during the adolescent period.  No studies have 
simultaneously examined the long-lasting effects of repeated AMPH exposure on both 
locomotor sensitization and more demanding forms of cognition, like working memory 
and reversal learning, in the same subjects.  
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Specific Aims 
Aim 1: To examine the neural correlates associated with repeated AMPH exposure and 
behavioral sensitization. 
 There is strong evidence of PFC plasticity in animals exposed to repeated 
AMPH.  Such long-lasting changes have been demonstrated morphologically in 
dendritic branching and spine density (Robinson and Kolb, 1999), as well as 
electrophysiological in mPFC neurons in vitro (Peterson et al, 2006), in anesthetized 
rats in vivo (Onn and Grace, 2000; Peterson et al., 2000; Trantham et al., 2002), and in 
awake rats (Homayoun and Moghaddam, 2006; Sun and Rebec, 2006).  Given that 
sensitization and neuroadaptations in the PFC are thought to be significant aspects 
responsible for driving behavioral changes associated with addiction, it is important to 
determine if there is a distinct relationship between neuronal activity and the emergence 
of locomotor adaptations.  In experiment 1, we used single-unit recording techniques to 
address the following question: Are there lasting changes in the response of mPFC 
neurons to AMPH when behavioral adaptations are evident?  The results of this study, 
which have been published (Gulley and Stanis, 2010) and are reproduced in Chapter 5, 
suggest that repeated AMPH led to very selective changes in mPFC function when 
behavioral sensitization was evident.  The magnitude of excitatory responses increased 
in parallel with sensitization, but were much less persistent following an AMPH 
challenge (when locomotor sensitization was most robust).  The data imply that 
particular populations of neurons are more vulnerable to AMPH-induced plasticity, and 
focusing in this notion will be key in future recording studies.    
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Aim 2: To determine if repeated AMPH exposure leads to enduring changes in 
sensitization and cognitive function, such as decision-making, working memory, and 
reversal learning. 
 Neuroadaptations in the PFC are hypothesized to play an important role in the 
behavioral changes associated with repeated psychostimulant drug exposure.  While 
such exposure is known to cause long-term changes in AMPH-induced locomotor 
behavior (i.e., sensitization), it is not clear, however, if repeated AMPH exposure 
produces long-term changes in cognitive behaviors that, in humans, are hypothesized to 
contribute to addiction.  In experiment 2, the following question was addressed: Does a 
repeated and intermittent AMPH exposure paradigm, which induces locomotor 
sensitization, alter decision-making?  Rats were repeatedly treated with AMPH and then 
trained and tested in an operant task (delay-discounting) that is sensitive to their 
inability to tolerate longer delays for a more advantageous food reward.  The results of 
this study, which have been published (Stanis et al., 2008b) and are reproduced in 
Chapter 2, suggest that the neuroadaptations known to be associated with locomotor 
sensitization do not overlap with those that lead to changes in impulsive choice 
behavior.  In experiment 3, we asked whether impulsivity might instead be a pre-existing 
trait.  The initial sensitivity to psychostimulants has been shown to predict their long-
term use and dependence in humans.  In rats, it has been shown that sensitivities to 
cocaine-induced locomotion are the result of differential cell-surface expression of the 
dopamine transporter (Briegleb et al., 2004), and the phenotype has been characterized 
on a number of other behavioral tasks in adult rats (e.g., Gulley et al., 2007; Allen et al., 
2007; Mandt et al., 2008; Klein and Gulley, 2009).  Experiment 3 addresses the 
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following question: Can we predict cognitive changes based on the initial sensitivity to 
the locomotor-activating effects a psychostimulant, such as cocaine?  The results of this 
study, which have been published (Stanis et al., 2008a) and are reproduced in Chapter 
3, suggest that differential sensitivity to cocaine-induced locomotion was predictive of 
impulsivity, and the potential differences could provide insight into the distinct neural 
mechanisms related to the vulnerability of addiction. 
The final experiment was designed to address a number of questions that 
remained about long-lasting consequences of AMPH exposure and cognitive function.  
Because the enduring consequences of repeated AMPH exposure might be dependent 
on dose and duration of treatment, and we know that human drug taking patterns are 
very different from those typically administered in an intermittent paradigm, a regimen of 
AMPH on an escalation schedule was followed by high-dose binge administration.  This 
model of escalation and binge has been understudied in animals, compared to the 
intermittent model.  Thus, is AMPH treatment regimen- and task-specific in its ability to 
influence behavioral and cognitive changes?  Moreover, adolescence in humans is a 
period of life when drug use, whether for therapeutic or recreational purposes, is often 
initiated.  Unfortunately, it is also a time when individuals develop long-lasting patterns 
of drug abuse and addictive behaviors.  Human and animal studies have revealed that 
during adolescence, brain areas such as the PFC are undergoing significant, yet 
normal, changes in synaptic connectivity.  These changes in synaptic organization have 
important implications and might interact with AMPH in a way that leads to harmful 
consequences.  Does exposure to AMPH during adolescence induce long-term 
modifications in behavior and cognitive function that endure into adulthood?  And based 
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on findings from experiment 3, is there also a predictable relationship between the initial 
sensitivity to cocaine-induced locomotion and more specific cognitive functions, namely 
working memory?  The results from this study suggest that chronic AMPH caused 
enduring consequences on cognitive function in both adolescent- and adult-treated rats, 
as tested in adulthood well after drug exposure ceased.  Importantly, the nature and 
timing of normal developmental changes interact with drug exposure in a method-
dependent manner.  In addition, the working memory deficits were predicted based on 
the initial sensitivity to cocaine.    
 
Summary 
 The number of prescriptions for amphetamine has dramatically increased by 
1600% over the last decade (Berman et al., 2009).  This is of huge concern because 
the abuse of prescription drugs has also been on the rise, especially in adolescents.  
Given that drug exposure during this time could have drastic, long-term effects on the 
brain and behavior, more studies are needed to examine age-dependent plasticity to 
psychostimulants, such as AMPH.  The experiments discussed here contribute new 
knowledge on the long-term consequences during adulthood from both adolescent-
and adult-AMPH exposed animals.  By revealing such consequences, we can better 
understand the underlying neural mechanisms to treat and perhaps even prevent 
abuse in the future.  Nevertheless, these studies contained here are of utmost 
importance to tease apart long-term effects based on the method of AMPH exposure 
and interactions with levels of vulnerability, such as the initial sensitivity to locomotor-
activating effects of a psychostimulant and the age of initial exposure.  Furthermore, 
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understanding the extent of drug-induced plasticity is an important step in 
characterizing transient and enduring changes that are associated with drug abuse 
and/or dependence.  Successful treatment options will likely need to take into 
account the individual spectrum of deficits observed. 
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CHAPTER 2: DISSOCIATION BETWEEN LONG-LASTING BEHAVIORAL 
SENSITIZATION TO AMPHETAMINE AND IMPULSIVE CHOICE IN RATS 
PERFORMING A DELAY-DISCOUNTING TASK1 
 
 
Abstract 
 
 Rationale: Repeated amphetamine (AMPH) exposure is known to cause long-
term changes in AMPH-induced locomotor behavior (i.e., sensitization) that are 
associated with similarly long-lasting changes in brain function.  It is not clear, however, 
if such exposure produces long-lasting changes in a cognitive behavior that, in humans, 
is hypothesized to contribute to addiction.  Objectives: To examine whether repeated 
AMPH exposure induces both locomotor sensitization and alters impulsive choice in a 
delay-discounting task.  Methods: Adult, male Sprague-Dawley rats (n = 29) were pre-
treated with 3.0 mg/kg AMPH or saline every other day for 20 days, and were then 
trained to lever press for small, immediately delivered food reinforcement or larger 
reinforcements delivered after delays.  We subsequently assessed the effects of acute 
AMPH (0.1-2.0 mg/kg) on delay-discounting.  Lastly, we tested for long-lasting effects of 
pre-treatment by giving an AMPH challenge (3.0 mg/kg) one week after the final delay-
discounting session.  Results: Repeated AMPH produced sensitization to the drug’s 
stereotypy-inducing effects, but did not alter acquisition or baseline behavior in the 
delay-discounting task.  Following acute AMPH, impulsive choice and other measures 
of delay-discounting were altered, but to a similar extent in both saline- and AMPH-
                                                 
1 This chapter appeared in its entirety in the journal Psychopharmacology as Stanis JJ, Marquez 
Avila H, White MD, Gulley JM (2008) Dissociation between long-lasting behavioral sensitization 
to amphetamine and impulsive choice in rats performing a delay-discounting task.  199(4):539-
548.  This article is reprinted with the permission of the publisher and is available from 
http://www.springerlink.com and using DOI: 10.1007/s00213-008-1182-z 
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pretreated groups.  The AMPH challenge, given ~3 months after the last pretreatment 
injection, revealed sensitization was still evident.  Conclusions: Our results suggest that 
one behavioral consequence of repeated AMPH exposure – sensitization – does not 
overlap with another potential outcome – increased impulsivity.  Furthermore, the 
neuroadaptations known to be associated with sensitization may be somewhat distinct 
from those that lead to changes in impulsive choice. 
 
Introduction 
While the locomotor effects and cellular adaptations that result from repeated 
amphetamine (AMPH) exposure have been well characterized (e.g., Robinson and 
Becker 1986; Seiden et al. 1993; Robinson and Kolb 1997, 1999; Lu and Wolf 1999), 
the long-term consequences of such exposure on measures of cognitive function are 
not as well established.  For instance, a number of clinical studies have demonstrated 
impairments in decision-making (Rogers et al. 1999; Ersche et al. 2006), concentration 
and attentional control (Deller and Sarter 1998; McKetin and Mattick 1998), and working 
memory (Ornstein et al. 2000).  However, most of these impairments were observed 
shortly after cessation of drug administration ( three days), thereby leaving the 
possibility that they were influenced by acute withdrawal effects rather than more long-
term, drug-induced neuroadaptations that might persist well beyond drug withdrawal.  
Also, the results observed in clinical studies may be influenced by the existence of 
polydrug abuse, varied duration and frequency of drug use and/or abstinence, and co-
morbid psychiatric disorders (Khantzian 1985; Levin and Kleber 1995; Rosselli and 
Ardila 1996). 
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Recent studies using animal models, which offer an advantage of control over 
many of these variables, have provided further insights into the long-term effects of 
repeated AMPH exposure on cognition.  For example, rats that exhibit behavioral 
sensitization have been shown to have deficits in tasks measuring attentional set-
shifting (Fletcher et al. 2005), sustained visual attention (Fletcher et al. 2007), pre-pulse 
and latent inhibition (Tenn et al. 2003, 2005), and, in primates, working memory 
(Castner et al. 2005).  Rats that self-administered AMPH over five different cycles of five 
days each, which were interspersed with a nine day drug-free period when they were 
tested in a five-choice serial reaction time task, exhibited deficits in visuospatial 
attention and no significant effects on perseverative (compulsive) or premature 
(impulsive) responding compared to yoked, saline-infused controls (Dalley et al. 2005).  
The changes in attentional performance recovered within five days of the withdrawal 
period, but reappeared following a two-month abstinence period and acute treatment 
with 0.8 mg/kg AMPH.  Impulsive responding was attenuated by this dose of AMPH in 
the group of rats with AMPH self-administration experience.   
Another task used to assess impulsive behavior in an operant reinforcement 
context is delay-discounting.  In this paradigm, the apparent value of reward can be 
shifted by manipulating the time delay between a required response and the delivery of 
an expected reinforcement (Evenden and Ryan 1996).  Specifically, small, immediately 
delivered reinforcements become more valuable than those that are large, but 
presented following a delay (Monterosso and Ainsle 1999).  Thus, in this paradigm, 
choices of small reinforcements are taken to reflect impulsive behavior.  Although 
increased impulsivity is considered to be characteristic of individuals who abuse drugs 
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(e.g., Jentsch and Taylor 1999; Coffey et al. 2003; Kirby and Petry 2004; Heil et al. 
2006; Hoffman et al. 2006; Verdejo-Garcia et al. 2007), there have been relatively few 
studies that have directly addressed the role of repeated psychostimulant exposure in 
altering impulsive choice behavior.  Those that have (e.g., Richards et al. 1999; Paine et 
al. 2003; Roesch et al. 2007; Simon et al. 2007) suggest that chronic treatment with 
methamphetamine or cocaine increases impulsivity.  However, a recent study by 
Winstanley et al. (2007) showed that repeated cocaine treatment did not alter baseline 
levels of impulsive choice.  While this study was extensive, details about cocaine-
induced locomotor activity (e.g., whether or not behavioral sensitization was observed) 
were not reported.            
In the current study, we examined whether one behavioral consequence of 
repeated AMPH exposure—behavioral sensitization—overlaps with another potential 
outcome—impulsive choice.  Because the delay-discounting task requires rats to be 
well-trained before responding becomes stable, any observed effects of AMPH 
pretreatment on task behavior are not likely to be due to disruptions caused by short-
term withdrawal effects.  After 40 daily sessions in the task, we examined whether acute 
treatment with saline (vehicle) or AMPH (0.1-2.0 mg/kg) just prior to delay-discounting 
test sessions altered subsequent task behavior.  Lastly, rats in both the saline and 
AMPH pretreatment groups were given a challenge injection of AMPH (3.0 mg/kg) to 
determine if long-lasting changes in locomotor activity were evident.  This challenge test 
occurred approximately 3 months after the last injection in the open-field. 
 
Methods 
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Animals.  Male Sprague-Dawley rats (n = 32), bred in our animal facility from 
stock rats obtained from Harlan (Indianapolis, IN), were housed individually starting at 
~2 months of age and were 3-4 months old (315-450 g) at the start of experiments.  
They were maintained on a 12:12 h light: dark cycle (lights on at 0800) with 
experimental sessions conducted between 0900 and 1800 h.  Rats were handled five 
times for 15 min intervals prior to being used in experiments.  With the exception of 
periods when rats were undergoing operant training and testing, food was available ad 
libitum.  Water was always available ad libitum.  All experimental procedures were 
approved by the IACUC at the University of Illinois, Urbana-Champaign and were 
consistent with the Principles of Laboratory Animal Care (NIH Publication no. 85-23). 
Apparatus.  Locomotor activity was measured in an open-field chamber that 
consisted of a transparent, Plexiglas box (40.6 x 40.6 x 40.6 cm) surrounded by 
photobeams (Coulbourn Instruments; Allentown, PA).  Each apparatus was connected 
to a computer operating software (TruScan, v. 2.01; Coulbourn Instruments) that 
recorded all horizontal and vertical beam breaks (100 ms sampling rate).  The horizontal 
beam breaks, or coordinate changes, were converted into ambulatory distance (cm).  
The chambers were individually contained inside sound-attenuating cubicles (76 x 80 x 
63 cm).  Each cubicle contained a speaker (76 mm dia.) fixed to one wall, two ceiling-
mounted white lights (4 W) for dim illumination, and a ceiling-mounted camera between 
the two lights.   
Operant behavior was monitored in standard operant conditioning chambers 
(Coulbourn Instruments).  One wall of the chamber contained two retractable levers that 
were positioned on either side of a centrally located food trough.  Infrared detectors 
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were used to monitor head entries into the food trough.  White cue lights were located 
above each lever.  A white houselight was located near the top of the chamber on the 
opposite wall.   
Repeated saline or AMPH treatment.  Prior to starting the 20-day, intermittent 
injection procedure, rats were first habituated to the open-field testing and injection 
procedures.  Specifically, they were brought to the testing room and, following a 20-min 
acclimation period during which they remained in their home cages, were placed in the 
open-field arena for 30 min.  They were then removed, injected with saline (1 ml/kg, 
i.p.), and returned to the arena for 60 min.  On the next day (i.e., treatment day 1), the 
same procedure was repeated except half of the rats (n = 16) received saline and the 
remainder were given AMPH (3.0 mg/kg, i.p.; n = 16).  Beginning on treatment day 2 
and continuing every other day until treatment day 9, rats were brought to the 
laboratory, injected with saline or AMPH, and allowed to behave for 60 min in an acrylic 
tub (46 x 25 x 22 cm) lined with hardwood bedding.  These tubs and bedding, which 
were identical to those used for the rat’s home cage in the animal colony, were used as 
a means to provide multiple injection environments and thereby minimize context-
dependent sensitization (Robinson and Becker 1986; Badiani and Robinson 2004).  On 
treatment day 10, the open-field testing procedure used on treatment day 1 was 
repeated.  Thus, rats received a total of 10 saline or AMPH injections over the course of 
20 days, with automated (i.e., photobeam) activity measures obtained on the first and 
final injection days.  The intermittent-dosing procedure was adapted from previous 
studies that showed impairments in object recognition memory (Bisagno et al. 2003; 
Belcher et al. 2006) and the development of behavioral sensitization (Robinson et al. 
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1985; Robinson and Becker 1986).  Furthermore, pilot studies revealed that rats given 
AMPH using this procedure exhibited progressive increases in focused stereotypy that 
persisted for at least one month after treatment.    
Delay-discounting behavior.  Following their last test in the open-field arena, rats 
were placed on food restriction and maintained at 85% of their free-feeding weight.  One 
week later, they were trained to respond on either of two independently available levers 
for a 45-mg food pellet (Bio-Serv; Frenchtown, NJ) on a fixed ratio schedule (FR1) of 
reinforcement during overnight sessions (2100 to 0900 hours).  After they displayed 
approximately equal responding on both levers, rats were moved to the next training 
phase (1-h sessions, between 0900 and 1700 h).  Trials began with levers retracted, 
and the food trough illuminated by a cue light.  A nosepoke into the trough resulted in 
the extension of one randomly selected lever, with a subsequent lever press response 
reinforced by delivery of a food pellet.  After 3-4 days of training at this stage, 14 saline 
pre-treated and 15 AMPH pre-treated rats began the final stage of training.  Three rats 
(n = 2 and 1 from the saline and AMPH pre-treated groups, respectively) failed to 
complete the first two training stages within 15 sessions and were thus removed from 
the study.  Two different cohorts of rats were trained on the task, with the second cohort 
responding for a different formulation of food pellet then the first (Bio-Serv products 
F0042 and F0021, respectively) at the end of training.  This switch was made because 
of pellet feeder clogging problems that developed towards the end of the second 
cohort’s training.  Statistical analysis of behavioral performance within cohort two 
following this switch, and between cohorts one and two, revealed no significant change 
in task performance.   
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Training in the delay-discounting task was done in daily, 100 min sessions that 
consisted of five blocks of 12 trials.  Each trial lasted 100 s and began with the 
illumination of the house light and cue light located in the food trough.  Rats were 
required to nosepoke into the trough within 10 s, whereupon a single lever would be 
presented randomly and a response was reinforced with food pellet delivery.  The 
amount of food delivered was pre-assigned to a lever, such that responses on one (e.g., 
left side lever) resulted in reinforcement that was large (four pellets) but delayed in 
delivery, and responses on the other (e.g., right side lever) resulted in an immediately 
delivered small reinforcement (one pellet).  Assignment of reward magnitude to levers 
was counterbalanced across groups, but remained consistent for each rat.  After a lever 
response, the house light turned off, the levers retracted, and the cue light above the 
lever was illuminated until food was delivered.  If the rat either failed to nosepoke within 
10 s or respond on the presented lever, the trial was recorded as an omission.  On 
omission trials, the levers remained retracted and the chamber was returned to an 
intertrial interval (ITI) state until the beginning of the next trial.  After completing or 
omitting the first two forced-choice trials (which served as exemplars for the each 
block), 10 free-choice trials were presented where both levers were extended.  Delays 
for the delivery of large rewards increased with each block of trials (0, 10, 20, 40, and 
60 seconds, respectively).  Each animal participated in one session per day, for a 
minimum of 40 training sessions.  
Following the last training session, the effects of AMPH on task behavior were 
assessed by administering rats injections of vehicle (saline; 1 ml/kg, i.p.) or AMPH (0.1, 
0.3, 0.6, 1.0, and 2.0 mg/kg, i.p.) 5 min before they were placed in the operant 
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conditioning chamber for a test session.  Injections were given over eight consecutive 
daily sessions in the order of VDDVDDVD (V = vehicle; D = drug).  The order of drug 
doses was chosen based on a Latin square design, with a particular order assigned to 
each rat randomly. The exception to this was the 2.0 mg/kg dose of AMPH, which was 
administered during the last session because pilot studies suggested this dose 
produced significant motor impairments that potentially could influence task 
performance in subsequent sessions. 
  Open-field behavior retest.  After the final session in the delay-discounting task, 
rats were given access to food ad libitum.  After one week, all rats were re-tested in the 
open-field with a challenge injection of 3.0 mg/kg AMPH.  The same procedures used 
during the initial open-field behavioral tests were followed, including the time of day 
experiments were performed.    
Drugs.  d-Amphetamine sulfate was obtained from Sigma-Aldrich (St. Louis, 
MO).  It was dissolved in sterile saline (0.9% NaCl), and dosages were calculated based 
on the weight of the salt.  All injections were given at a volume of 1 ml/kg. 
Data Analyses.  Data were imported into a relational database (SQL Server 2005 
Developer, Microsoft; Seattle, WA) and analyzed using SAS 9.1 (SAS Institute, Inc.; 
Cary, NC) or SigmaStat 3.5 (Systat Software, Inc.; San Jose, CA).  All graphs show 
group means ± SEM.  The effects of saline or AMPH on open-field behavior were 
analyzed using two-way, mixed factor ANOVA, with group as the between-subjects 
factor and treatment day as the repeated measure.  Because 3.0 mg/kg AMPH tends to 
produce stereotyped patterns of behavior (i.e., repetitive head movements or sniffing), 
we also used a semi-quantitative scoring method (adapted from Gulley et al. 2004) to 
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describe observed behavior.  Raters blind to treatment conditions scored 30 sec 
segments of video taken every 5 min of the 60 min post-injection period.  For each 
segment, the duration (0-30 sec) and intensity (1 – mild; 2 – moderate; 3 – intense) of 
focused stereotypy were recorded and these scores were then multiplied to give a 
single value (ranging from 0-90).  These data were analyzed using three-way, mixed 
factor ANOVA with time and treatment day as within-subjects factors and group as the 
between-subjects factor.  Follow-up analyses of significant interactions were performed 
with one- or two-way ANOVA and Holm-Sidak post-hoc tests.        
For analysis of delay-discounting behavior, several measures were used.  Choice 
behavior was represented as mean choice of the large reinforcer for free-choice trials 
only.  The progression of task performance across sessions was assessed by obtaining 
these data during early acquisition (sessions 1-3), training midpoint (18-20), and stable 
baseline (sessions 41, 44, and 47).  The stable baseline period encompassed the three 
sessions during which rats were given saline injections before they began the task.  
Data were analyzed with two-way repeated-measures ANOVA (treatment condition x 
delay).  Data from tests of the acute effects of AMPH on task performance were 
analyzed using multifactorial ANOVA with treatment condition as a between-subjects 
factor and dose and delay as within-subjects factors.  When appropriate, Holm-Sidak 
post-hoc tests were performed.  Missing values were excluded from analysis.  In cases 
where the assumption of sphericity was violated in repeated measures ANOVA, a 
multivariate analysis was used instead.   In all tests, p values less than 0.05 were 
considered significant. 
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Results 
Locomotor behavior 
 As expected, 3.0 mg/kg AMPH had robust effects on locomotor activity (Fig. 2.1).  
We observed significant main effects of group [F(1,936) = 174, p<.001], treatment day 
[F(2,936) = 61.5, p<.001], and time [F(11,936) = 2.58, p<.01] , along with a group x 
treatment day interaction [F(2,936) = 255, p<.001] and a three-way interaction 
[F(22,936) = 6.01, p<.001].  In the AMPH-pretreated group, the first drug exposure 
produced a significant increase in ambulation, compared to rats given saline (Day 2, 
Fig. 2.1A).  After repeated AMPH treatment (10 injections; Day 20), however, 
ambulatory distance was significantly reduced compared to their first AMPH treatment 
day.  This reduction, which was first apparent at 20 min following injection and became 
statistically significant at 45 min post injection, was due to the onset of focused 
stereotypy.  As shown in Fig. 2.1B, the first exposure to AMPH led to increases in 
stereotypy that became maximal at ~50 min following injection.  After repeated 
exposure, rats in the AMPH pretreatment group exhibited maximal stereotypy by 30-min 
post injection.  Mixed-factor ANOVA of these data revealed significant main effects for 
group [F(1,924) = 1420, p<.001], treatment day [F(2,924) = 217, p<.001], and time 
[F(11,924) = 44.8, p<.001], with a group x treatment day interaction  [F(2,924) = 33.2, 
p<.001], and a three-way interaction  [F(22,924) = 2.06, p<.001].    
One week after they finished testing in the delay-discounting task (see below), 
rats were re-tested in the open-field arena.  During these tests, which occurred ~ 3 
months after their last open-field test session (i.e., treatment day 20), rats in both 
groups were injected with 3.0 mg/kg AMPH in the open-field arena.  Rats in the saline 
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pretreated group exhibited significant increases in both ambulation and stereotypy 
compared to their last saline test session (Fig. 2.1A and B).  These effects were not 
significantly different from those observed in AMPH pretreated rats following their first 
AMPH injection, but it was different from drug-induced behavior in the AMPH pretreated 
group at re-test.  In the AMPH-pretreated rats, there was no significant difference in 
ambulation at re-test compared to treatment day 20.  Stereotypy was actually enhanced 
after the ~ 3 month time lapse between injections of this AMPH dose, with scores 
reaching maximal values earlier in the 60 min post-injection time period (Fig. 2.1B).     
 
Delay-discounting behavior  
 As shown in Fig. 2.2, prior exposure to AMPH did not alter delay-discounting 
behavior.  There were no significant differences between saline and AMPH treatment 
groups during the early phase of task acquisition (sessions 1-3), at the midpoint of 
training (sessions 18-20), and during baseline (sessions 41, 44, and 47).   Rats in both 
groups did exhibit a robust sensitivity to delay by reducing their responding on the large 
reward lever as the delay increased to a maximum of 60 s.  The main effect of delay 
was significant at all three training stages [acquisition: F(4,24) = 4.33, p<.01; midpoint: 
F(4,24) = 22.0, p<.001; and baseline: F(4,24) = 73.5, p<.001].  As shown in Fig. 2.2A, 
the sensitivity to delay was apparent at the earliest stages of task acquisition, although it 
was not as pronounced during the 0-20 s delays compared to later sessions (Fig 2.2B 
and C).  The number of trial omissions was relatively low, with rats in saline and AMPH 
pre-treatment groups omitting a total of 0.376 ± 0.114 and 0.196 ± 0.11 trials, 
respectively, across all delays during the midpoint sessions.  This small group 
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difference was not statistically significant, and neither were the small group differences 
in trial omissions at acquisition [saline: 1.18 ± 0.39; AMPH: 0.97 ± 0.38] and baseline 
[saline: 0.31 ± 0.09; AMPH: 0.16 ± 0.09].    
When AMPH was administered 5 min before the start of the task, it induced a 
dose-dependent change in choice behavior [dose: F(5,810) = 20.7, p<.001)] that varied 
as a function of delay [dose x delay: F(4,810) = 117, p<.001], but was not significantly 
different in saline and AMPH pretreated rats.  Subsequent analysis of AMPH effects in 
the different treatment groups with two-way ANOVA and post-hoc analysis revealed that 
the 2.0 mg/kg AMPH significantly decreased choice of the large reward at the 0 and 10 
s delays for saline pretreated rats and the 0, 10 and 20 s delays for those pretreated 
with AMPH (Fig. 2.3A-B).  The number of trial omissions (Fig. 2.3C) and latencies to 
nosepoke or lever press (Fig. 2.4), in contrast, were increased over a wider range of 
AMPH doses and there were differential effects in the pretreatment groups.  For 
omissions, we observed significant main effects of group [F(1,810) = 4.19, p<.05], dose 
[F(5,810) = 155, p<.001], and a group x dose interaction [F(5,810) = 50.3, p<.001].  
Pairwise comparisons revealed that the 1.0 and 2.0 mg/kg doses were significantly 
different from vehicle, and the 2.0 mg/kg dose produced the most robust effect.  The 
effects of the highest dose were most pronounced in the AMPH-pretreated group. 
The latency to nosepoke for presentation of levers, as well as to respond on a 
lever, was increased by AMPH to a similar extent in both groups (Fig. 2.4A).  There 
were significant main effects of dose for both measures [nosepoke latency: F(5,22) = 
3.68, p<.01; lever press latency: F(5,16) = 3.53, p < .05], with the 2 mg/kg dose 
increasing latency to the greatest extent compared to vehicle injections.  The number of 
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nosepoke responses that rats made during periods when food pellets were not 
available—during ITIs and during delays following responses on the large reward 
lever—were decreased by all doses of AMPH (Fig. 2.4B and C).  For nosepoke 
responses during ITIs and delays, only the main effects of dose were significant [ITIs: 
F(5,23) = 8.64, p<.001; delays: F(5,23) = 4.37, p<.01].  More specifically, all doses of 
AMPH reduced the number of nosepoke responses compared to vehicle sessions.  This 
effect tended to be greater in AMPH-pretreated rats, but the main effect of group and 
the group x dose interaction were not significant.  Also, the saline-pretreated group 
made more nosepoke responses during ITIs than the AMPH-pretreated group after 
vehicle and the highest tested doses of AMPH (Fig. 2.4B), although this effect was not 
statistically significant. 
 
Discussion 
Repeated exposure to 3.0 mg/kg AMPH produced robust changes in AMPH-
induced locomotor activity in an open-field arena that was evident following 10 injections 
in 20 days.  This treatment did not, however, alter baseline choice behavior in a delay 
discounting task.  There were subtle effects on task performance when AMPH was 
given prior to the sessions, but these were likely due to motor disruptions produced by 
the higher doses and may be a reflection of the higher sensitivity to AMPH’s locomotor 
effects that were observed in the open-field for this group.  When rats in the AMPH 
pretreatment were given an AMPH challenge in the open-field after the conclusion of 
their final delay-discounting session—a procedure that occurred ~3 months after their 
last injection in the open-field—the sensitization to AMPH’s stereotypy-inducing effects 
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was still evident and slightly enhanced.  Rats in the saline pretreatment group exhibited 
AMPH-induced behavior that was not significantly different from that observed in the 
AMPH pretreatment group following their first drug injection.  Taken together, these 
findings suggest that the long-lasting locomotor effects of repeated, intermittent AMPH 
exposure can be dissociated from effects on delay-discounting behavior.  Furthermore, 
our results suggest that the neuroadaptations that resulted from repeated AMPH 
exposure, which are known to be associated with sensitization (Robinson and Berridge 
2000), do not cause enduring deficits in the aspects of cognition that the delay-
discounting task requires.  It is not clear from the current study if the observed 
dissociation is specific to the dosing procedure used, but it is notable that previous 
studies using similar AMPH treatment schedules have reported a reduction in 
subsequent structural plasticity and forms of new learning (Kolb et al. 2003; Briand et al. 
2005), as well as impairments in object recognition memory (Bisagno et al. 2003; 
Belcher et al. 2006).   
With respect to the long-lasting sensitization that was observed in AMPH 
pretreated rats, it should be noted that these rats received an additional cumulative 
dose of 4.0 mg/kg AMPH across the 8 days of drug and vehicle testing in the delay-
discounting task.  The saline pre-treated group also had this same level of exposure, 
however, and their response to AMPH challenge was no different from that seen in 
AMPH pretreated rats after their first drug exposure. Thus, this additional exposure to 
AMPH is unlikely to account for the persistence of sensitization.  Similar long-lasting 
changes in AMPH-induced behavior have been observed previously (Segal and Mandell 
1974; Klawans and Margolin 1975; Kolta et al. 1985; Robinson and Becker 1986). 
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To our knowledge, no published studies have described the effects of chronic 
AMPH exposure on delay-discounting behavior in an animal model, but several have 
examined other psychostimulants (Richards et al. 1999; Paine et al. 2003; Roesch et al. 
2007; Simon et al. 2007; Winstanley et al. 2007).  While most of these reports 
suggested that repeated psychostimulant exposure increases impulsive decisions, the 
most extensive study to date (Winstanley et al. 2007) reported no baseline impairments 
in impulsive choice in rats exposed repeatedly to cocaine (15 mg/kg, i.p., for 21 days).  
Unfortunately, they did not report locomotor behavior, or more specifically, if behavioral 
sensitization was observed.  As for the remaining studies, there are key factors that 
differ between each of them and ours.  In the studies by Richards et al. (1999) and 
Paine et al. (2003), drug treatment began after training in the task was completed and 
injections were given following daily delay-discounting sessions.  Interestingly, Paine et 
al. (2003) reported that increased impulsive choice in rats was only observed in 
association with behavioral sensitization (i.e., on day 7 of cocaine treatment; 15 mg/kg, 
3 injections/day for 14 days), and choice behavior returned to baseline levels on 
subsequent days even though sensitization persisted or was enhanced.  In a study by 
Simon et al. (2007) that utilized chronic treatment with a high dose of cocaine (30 mg/kg 
daily for 14 days), cue lights did not remain illuminated during the delay periods that 
occurred following responses on the large reward lever.  The absence of cues has 
previously been shown to decrease rat’s choices of the large reward lever (Cardinal et 
al. 2000), which is what the authors reported.   
Simon et al. (2007) also observed a reduction in the number of nosepoke 
responses into the food trough during the delay periods prior to reward delivery.  
 31 
Interestingly, we did not observe this difference during vehicle sessions.  At all tested 
doses of AMPH, however, we did find this effect.  This is likely a separate construct 
from impulsive choice (Evenden 1999) and has been referred to as impulsive action.  A 
few studies have addressed the influence of chronic AMPH exposure on impulsive 
action, and a task commonly used to test this characteristic is differential reinforcement 
of low rates of responding.  Using this task, increased impulsive action was observed in 
AMPH-treated rats immediately following treatment (5.0 mg/kg for 9 days), but this only 
persisted for 9 days after the cessation of drug exposure (Peterson et al. 2003).  Once 
again, these findings suggest that impulsive behavior is only transiently altered by 
repeated AMPH exposure.    
In the present study, injections of 0.1-1.0 mg/kg AMPH had subtle effects on 
choice behavior in both pre-treatment groups.  The 2.0 mg/kg dose increased the 
number of omissions and latencies to both nosepoke and lever press, with the AMPH-
pretreated group exhibiting significantly more omissions than the saline-pretreated 
group.   There are several reports indicating that acute AMPH treatment either dose-
dependently reduces (Cardinal et al. 2000; deWit et al. 2002; Winstanley et al. 2003; 
vanGaalen et al. 2006), increases (Evenden and Ryan 1996; Cardinal et al. 2000), or 
has little to no effect (Uslaner and Robinson 2006) on impulsive choice in a delay-
discounting paradigm.  It is unclear why the results of these various studies are 
somewhat equivocal, but differences in baseline choice behavior have been shown to 
influence the effects of AMPH on delay discounting.  For example, Winstanley et al. 
(2003) have suggested that AMPH decreases impulsive choice in rats that tend to have 
higher levels of impulsive choice before drug treatment.  A recent study (Barbelivien et 
 32 
al. 2008), which systematically examined the interaction between baseline choice 
behavior and AMPH’s effects on delay discounting, revealed that AMPH significantly 
decreased impulsive choice in rats with a “medium” basal level of impulsive choice and 
had no significant effect in those with either low or high baseline levels.  In the present 
study, our sample was not sufficiently large to appropriately analyze sub-populations of 
rats with diverse choice behavior at baseline, but we did note a trend for AMPH to 
decrease impulsive choice most in rats with high to medium baseline levels, and an 
opposite effect in animals with low baseline levels of impulsive choice.    
While current theories of drug addiction suggest that heightened impulsivity is a 
common characteristic of individuals who abuse drugs (Jentsch and Taylor 1999; 
Lyvers 2000; Goldstein and Volkow 2002; Bechara 2005), it is not clear whether this is a 
major contributing factor to the development of addiction or if it is caused by repeated 
drug exposure.  Our study in rats suggests that increased impulsive choice is not an 
inevitable consequence of repeated, intermittent exposure to AMPH.  Instead, it 
supports the notion that, at least in rats, a high degree of impulsivity is more likely a pre-
existing trait that is potentially amplified by exposure to drugs (Bechara 2005; Dalley et 
al. 2007).  Similarly, evidence from clinical studies (Ersche et al. 2008) suggests that 
repeated drug exposure does not lead to generalized effects: chronic cocaine use was 
associated with perseverative responding, whereas chronic amphetamine use was not.  
Taken together, these studies and our results underscore the importance of avoiding 
generalization between drugs of abuse and ensuing changes in behavior and the brain.  
Furthermore, our study suggests that the neuroadaptations that are known to be 
associated with the long-lasting expression of behavioral sensitization (Robinson and 
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Berridge 2000) may not have wide-ranging consequences for other behaviors that are 
considered to be associated with, or characteristic of, addiction.  Rather, there may be a 
unique or potentially overlapping set of drug-induced neuroadaptations that lead to 
heightened impulsivity.  
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CHAPTER 3: DISPARATE COCAINE-INDUCED LOCOMOTION AS A PREDICTOR 
OF CHOICE BEHAVIOR IN RATS TRAINED IN A DELAY-DISCOUNTING TASK
2 
 
 
Abstract 
Heightened impulsivity and differential sensitivity to a drug’s behavioral effects 
are traits that, individually, have been associated with chronic drug use and 
dependence.  Here, we used an animal model to test whether individual differences in 
cocaine-induced activity are predictive of impulsive choice behavior.  Adult, male 
Sprague-Dawley rats were given cocaine (10 mg/kg, i.p.) and classified into low or high 
cocaine responders (LCRs and HCRs, respectively) based on their locomotor response 
in an open-field arena.  Rats were then trained in a delay-discounting task that offers a 
choice between immediately delivered, but smaller reinforcements, or larger 
reinforcements that are delivered after a delay.  We also examined the effects of 
amphetamine (AMPH; 0.3-1.0 mg/kg) and the 5-HT1A agonist 8-OH-DPAT (0.3-1.0 
mg/kg) on delay discounting.  Lastly, all rats were retested in the open-field to determine 
if phenotypes were stable.  We observed baseline differences in choice behavior 
between the groups, with HCRs behaving more impulsively (i.e., choosing the small 
reinforcement) compared to LCRs.  AMPH decreased choice of the large reinforcement 
in LCRs, but did not alter choice in HCRs.  Impulsive choice was increased in both 
phenotypes following 8-OH-DPAT, with LCRs exhibiting changes across a wider range 
of delays.  When cocaine-induced open-field behavior was retested, responses in LCRs 
                                                 
2
 This chapter appeared in its entirety in the journal Drug and Alcohol Dependence as Stanis JJ, 
Burns RM, Sherrill LK, Gulley JM (2008) Disparate cocaine-induced locomotion as a predictor of 
choice behavior in rats trained in a delay-discounting task. 98(1-2):54-62.  This article is 
reprinted with the permission of the publisher and is available from 
http://www.sciencedirect.com and using DOI: 10.1016/j.drugalcdep.2008.04.009 
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were similar whereas HCRs showed evidence of tolerance.  Our results suggest that 
differential sensitivity to cocaine-induced locomotion is predictive of impulsivity and the 
potential neurobiological differences in LCRs and HCRs may provide insight into 
mechanisms contributing to vulnerability for chronic drug use and/or dependence. 
 
Introduction 
Impulsivity is a complex, multifaceted trait that is broadly defined by a lack of 
behavioral inhibition, which includes premature and poorly controlled actions, and 
impulsive choice, where decisions are poorly conceived and sensitive to delayed 
rewards (see Evenden, 1999; Winstanley et al., 2006a for more detailed accounts).  
Individuals who abuse drugs tend to exhibit heightened levels of these traits, particularly 
with regards to impulsive decision-making (Bornovalova et al., 2005; Coffey et al., 2003; 
Heil et al., 2006; Kirby and Petry, 2004; Lejuez et al., 2007; Moeller et al., 2002; 
Verdejo-Garcia et al., 2007).  It has been suggested that a high level of impulsivity 
develops as a result of repeated exposure to abused drugs, and this in turn facilitates 
the development and/or maintenance of addiction (Jentsch and Taylor, 1999).  
Evidence supporting this hypothesis comes in part from studies using animal models, 
where repeated exposure to cocaine in rats leads to an increase in impulsive choice 
behavior relative to that observed in saline-treated controls (Paine et al., 2003; Roesch 
et al., 2007; Simon et al., 2007), and from clinical studies, where individuals who have 
been chronically exposed to cocaine show increases in impulsive choice relative to non-
drug users or drug abstainers (for review, see Bickel and Marsch, 2001 and Reynolds, 
2006).        
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An alternative and not necessarily mutually exclusive hypothesis is that a high 
level of impulsivity is a pre-existing trait whose multidimensional components overlap 
with other traits or behaviors that also confer enhanced vulnerability to chronic drug use 
and/or dependence (Bechara, 2005; Dalley et al., 2007a, b; Kreek et al., 2005).  An 
example of one such candidate trait is differential sensitivity to a drug’s behavioral 
effects.  In humans, for example, differences in initial sensitivity to cocaine are 
predictive of long-term use and dependence (Davidson et al., 1993; Haertzen et al., 
1983; Schafer and Brown, 1991), and a recent study has indicated that individuals who 
reported a high degree of “liking” or “wanting” on their initial use of cocaine had a 
significantly increased risk of cocaine abuse (Lambert et al., 2006).  In rodents, a 
reliable indicator of initial sensitivity to psychostimulants is drug-induced locomotor 
activity in an open-field arena.  Cocaine, in particular (Briegleb et al., 2004), has 
variable stimulant effects on behavior, such that outbred rats can readily be classified as 
low or high cocaine responders (LCRs or HCRs, respectively) based on their response 
to a single treatment with cocaine (Sabeti et al., 2002; Gulley et al., 2003; Gulley, 2007).  
Interestingly, these individual differences are related to differences in the function of 
dopamine transporters (DATs) in the dorsal striatum and nucleus accumbens (Sabeti et 
al., 2002, 2003), and not to pharmacokinetic factors (Gulley et al., 2003).  Subsequent 
studies have shown that the LCR/HCR phenotype can be used to predict behavior in a 
food-reinforced operant task (Gulley, 2007), as well as conditioned place preference for 
cocaine (Allen et al., 2007).   
In the current study, we used rats to examine if differential sensitivity to the 
locomotor activating effects of cocaine were predictive of one component of impulsivity, 
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impulsive choice behavior.  Rats were first characterized as LCRs and HCRs based on 
their response to 10 mg/kg cocaine in an open-field arena.  They were then trained in a 
delay-discounting task that offered a choice between immediately delivered, but smaller 
reinforcements, or larger reinforcements that were delivered after a delay of up to 60 s.  
After 34 daily training sessions, we performed a series of drug challenges in order to 
determine if impulsive choice could be altered in a differential manner between LCRs 
and HCRs.  First, rats were given amphetamine (AMPH; 0.3-1.0 mg/kg) or saline prior 
to the start of daily delay-discounting sessions.  AMPH has been shown previously to 
increase or decrease delay-discounting behavior (Cardinal et al., 2000; Evenden and 
Ryan, 1996, 1999; van Gaalen et al., 2006), and it has been suggested that an 
individual’s baseline level of impulsive choice behavior influences this response 
(Barbelivien et al., 2008; Winstanley et al., 2003).  Rats were then challenged with the 
5-HT1A agonist 8-OH-DPAT (0.3-1.0 mg/kg) or saline prior to their daily session.  8-OH-
DPAT has been shown to increase impulsive choice (Winstanley et al., 2005; but see 
Evenden and Ryan, 1999; Poulos et al., 1996) and it is not clear if this effect depends 
on the baseline level of impulsive choice.  Lastly, all rats were re-tested in the open-field 
for their response to cocaine in order to assess if the phenotypic differences in cocaine 
response that were established initially remained stable following the ~3 months time 
period that elapsed during the course of the study. 
 
Methods 
Animals.  Male Sprague-Dawley rats (n = 16), bred in our animal facility from 
stock rats obtained from Harlan (Indianapolis, IN), were housed individually starting at 
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~2 months of age and were 3-3.5 months old (300-490 g) at the start of experiments.  
They were maintained on a 12:12 h light: dark cycle (lights on at 0800) with 
experimental sessions conducted between 0900 and 1800 h.  Rats were handled five 
times for 15 min intervals prior to being used in experiments.  With the exception of 
periods when rats were undergoing operant training and testing, food was available ad 
libitum.  Water was always available ad libitum.  All experimental procedures were 
approved by the IACUC at the University of Illinois, Urbana-Champaign and were 
consistent with the Principles of Laboratory Animal Care (NIH Publication no. 85-23). 
Apparatus.  Locomotor activity was measured in an open-field chamber that 
consisted of a transparent, Plexiglas box (40.6 x 40.6 x 40.6 cm) surrounded by 
photobeams (Coulbourn Instruments; Allentown, PA).  Each apparatus was connected 
to a computer operating software (TruScan, v. 2.01; Coulbourn Instruments) that 
recorded all horizontal and vertical beam breaks (100 ms sampling rate).  The horizontal 
beam breaks, or coordinate changes, were converted into distance traveled (cm).  The 
chambers were individually contained inside sound-attenuating cubicles (76 x 80 x 63 
cm).  Each cubicle contained a speaker (76 mm dia.) fixed to one wall, two ceiling-
mounted white lights (4 W) for dim illumination, and a ceiling-mounted camera between 
the two lights.  White nose (70 dB) was played continuously through the speakers when 
rats were in the testing room.   
Operant behavior was monitored in standard operant chambers (Coulbourn 
Instruments).  One wall of the chamber contained two retractable levers that were 
positioned on either side of a centrally located food trough.  Infrared detectors were 
used to monitor head entries into the food trough.  White cue lights were located above 
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each lever.  A white houselight was located near the top of the chamber on the opposite 
wall. 
Initial behavioral characterization: Locomotor activity in the open-field.  After a 
30-min acclimation period in the testing room, rats were placed in the open-field 
chambers for 90 min.  They were then removed from the chamber, injected (i.p.) with (-) 
cocaine HCl (10 mg/kg) and placed back into the chamber for an additional 60 min.  
This dose was chosen based on previous studies (Sabeti et al, 2002; Gulley et al, 2003) 
showing that it is optimal for inducing the widest range of behavioral responses in male 
Sprague-Dawley rats.    After the testing session, rats were returned to the colony room 
and their access to food was restricted so that they were reduced to 85% of their free-
feeding weight over the course of several days.  Rats were maintained at 85-90% of 
free-feeding weight for the duration of operant training and testing.  
Delay-discounting behavior.  Seven days after the open-field test, rats were 
trained in overnight sessions (2100 to 0900 hours) to respond on either of two available 
levers for a food pellet (45-mg; Bio-Serv F0021 or F0042) on a fixed ratio schedule 
(FR1) of reinforcement.  After they displayed approximately equal responding on both 
levers, rats were moved to the next training phase (1-h sessions, between 0900 and 
1700 h).  Trials began with levers retracted, and the food trough illuminated by a cue 
light.  A nosepoke into the trough resulted in the extension of one randomly selected 
lever, with a subsequent lever press response reinforced by delivery of a food pellet.  
After 3-4 days of training at this stage, rats began the final stage of training.     
Training in the delay-discounting task was done in daily, 100 min sessions that 
consisted of five blocks of 12 trials.  Each trial lasted 100 s and began with the 
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illumination of the house light and cue light located in the food trough.  Rats were 
required to nosepoke into the trough within 10 s, whereupon a single lever would be 
presented randomly and a response was reinforced with food pellet delivery.  The 
amount of food delivered was pre-assigned to a lever, such that responses on one (e.g., 
left side lever) resulted in a larger, delayed reward of four pellets and responses on the 
other (e.g., right side lever) resulted in a small, immediate reward of one pellet.  
Assignment of reward magnitude to levers was counterbalanced across groups, but 
remained consistent for each rat.  After a lever response, the house light turned off, the 
levers retracted, and the cue light above the lever was illuminated until food was 
delivered.  If the rat either failed to nosepoke within 10 s or respond on the presented 
lever, the trial was recorded as an omission.  On omission trials, the levers remained 
retracted and the chamber was returned to an intertrial interval (ITI) state until the 
beginning of the next trial.  After completing or omitting the first two forced-choice trials 
(which served as exemplars for each block), 10 free-choice trials were presented where 
both levers were extended.  Delays for the delivery of large rewards increased with 
each block of trials (0, 10, 20, 40, and 60 seconds, respectively).  Each animal 
participated in one session per day, for a minimum of 34 training sessions.  
Following the last training session, the effects of AMPH or 8-OH-DPAT on task 
behavior were assessed in two testing blocks.  For the first testing block, rats were 
given injections of vehicle (saline; 1 ml/kg, i.p.) or AMPH (0.3, 0.6, 1.0 mg/kg, i.p.) 5 min 
before they were placed in the operant chamber for a test session.  Saline or drug 
injections were given in an alternating fashion over six consecutive daily sessions (i.e., 
SDSDSD, where S = saline and D = drug).  The order of drug doses was chosen based 
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on a Latin square design, with a particular order assigned to each rat randomly.  Rats 
were given a five day break after the last AMPH test session.  Subsequently, they were 
allowed a session without any injections, followed on the next day by the start of the 
second testing block.  For these tests, saline or 8-OH-DPAT (0.3, 0.6. and 1.0 mg/kg, 
i.p.) was given using the same procedure as was used in the first testing block. 
Open-field behavior retest.  After their final session in the delay-discounting task, 
rats were given access to food ad libitum.  One week later, they were re-tested in the 
open-field with 10 mg/kg cocaine (i.p.).  The same procedures used during the initial 
open-field behavioral characterization test were followed, including the time of day 
experiments were performed.    
Drugs.  The (-) cocaine HCl used in this study was obtained from NIDA (RTI 
International; Research Triangle Park, NC).  d-Amphetamine sulfate and 8-OH-DPAT 
were obtained from Sigma-Aldrich (St. Louis, MO).  Drugs were dissolved in sterile 
saline (0.9% NaCl), with dosages calculated based on the weight of the salt.  All 
injections were given at a volume of 1 ml/kg. 
Data Analyses.  All analyses were conducted using SAS 9.1 (SAS Institute, Inc.; 
Cary, NC), SigmaStat 3.5 (Systat Software, Inc.; San Jose, CA), and SQL Server 2005 
Developer (Microsoft; Seattle, WA).  Cocaine-induced locomotor activity in the open-
field was assessed by determining the cumulative activity during the first 30-min 
following injection. As in previous studies (Gulley et al., 2003; Gulley, 2007), rats with 
activity scores in the lower half of the population distribution were designated LCRs and 
those in the upper half were designated HCRs.  The statistical significance of group 
differences in cocaine-induced activity was determined using two-way, mixed factor 
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ANOVA, with group as the between-subjects factor and test session as the repeated 
measure.  The locomotor response to a novel environment was also assessed by 
determining the cumulative activity during the first 30-min following placement into the 
open-field arena; group differences were analyzed with a one-way ANOVA.   
Several measures were used to analyze delay-discounting behavior.  Choice 
behavior was represented as mean choice of the large reward for free-choice trials only.  
The progression of task performance across sessions was assessed by obtaining these 
data during early acquisition (sessions 1-3), training midpoint (15-17), and stable 
baseline (sessions 35, 37, and 39).  The stable baseline period encompassed the three 
sessions during which rats were given saline injections before they began the task.  
Data from each of these training endpoints were analyzed with two-way repeated-
measures ANOVA (group x delay, as well as session x delay for sessions 32-34).  In 
order for behavior to be considered stable, the session factor had to be non-significant, 
while the delay factor had to be significant.  Data from tests of the acute effects of 
AMPH or 8-OH-DPAT on task performance were analyzed using multifactorial ANOVA 
with group as a between-subjects factor and dose and delay as within-subjects factors.  
Further ANOVAs were performed (with session and delay as within-subject factors) to 
test for stability in behavior between vehicle injections.  When appropriate, Holm-Sidak 
post-hoc tests were performed.  In all tests, p values less than 0.05 were considered 
significant. 
 
Results 
Open-field behavior  
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The first exposure to 10 mg/kg cocaine resulted in disparate locomotor activity 
that could be described by separating rats into LCRs and HCRs.  As shown in Fig. 3.1, 
LCRs exhibited, on average, 61% less cocaine-induced activity compared to that 
observed in HCRs.  This group difference in behavior was statistically significant [main 
effect of group: F(1,14) = 27.0, p < 0.001].  Novelty-induced activity was also lower in 
LCRs (10,206 ± 895 cm) compared to HCRs (12,822 ± 854 cm), but this difference was 
not statistically significant.  Following the completion of training and testing in the delay-
discounting task (see below), rats were retested in the open-field arena for their 
response to 10 mg/kg cocaine.  During the ~3 month period that elapsed between the 
first and second tests, these rats were never exposed to the open-field chambers or the 
testing room in which the chambers were housed.  As shown in Fig. 3.1, we found that 
cocaine-induced activity in LCRs was similar in both tests.  HCRs, in contrast, exhibited 
less activation on retest compared to their initial characterization.  These effects were 
reflected in a significant interaction between group and test session [F(1,14) = 6.47, p < 
0.05].  Cocaine-induced activity in LCRs and HCRs was not significantly different on 
retest.   
 
Delay-discounting behavior 
 As shown in Fig. 3.2, there were differences in delay-discounting behavior 
between LCRs and HCRs.  We observed significant main effects of group [F(1,210) = 
29.4, p < 0.001], training period [F(2,210) = 11.3, p < 0.001], and delay [F(4,210) = 29.5, 
p < 0.001].  More specifically, group differences in delay-discounting were significant 
during the midpoint of training [sessions 15-17; group x delay interaction: F(4,56) = 
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37.6, p < 0.05] and at stable baseline [sessions 35, 37, and 39; group x delay 
interaction: F(4,56) = 30.7, p < 0.01], but not during the early phase of task acquisition 
(Fig. 3.2A-C).  As expected, rats in both groups exhibited sensitivity to delay by 
reducing their responding on the large reward lever as their number of days in training 
increased.  As shown in Fig. 3.2A, the sensitivity to delay was emerging in the earliest 
stages of task acquisition, primarily at the 40- and 60-s delays.  As training progressed, 
rats in both groups chose the large reward almost exclusively when there was no delay, 
and progressively less often as delay increased.  Furthermore, discounting was less 
steep in LCRs compared to HCRs.  This was most apparent at the midpoint of training, 
where the groups differed at the 10, 20, and 40 s delays (Fig. 3.2B).  At stable baseline, 
LCRs continued to choose the large reward more frequently than HCRs across these 
same delays, although the difference at 20 s was the only one that was statistically 
significant (Fig. 3.2C).  The number of trial omissions was relatively low for both groups, 
with LCRs and HCRs omitting a total of 0.36 ± 0.27 and 0.33 ± 0.27 trials, respectively, 
across all delays during the midpoint sessions.  The small group difference was not 
statistically significant, and neither were those at acquisition (LCRs: 1.81 ± 0.74 trials; 
HCRs: 0.65 ± 0.74 trials) or baseline (LCRs: 0.08 ± 0.06 trials; HCRs: 0.09 ± 0.06 trials).  
 
Effects of AMPH on delay-discounting  
When AMPH was administered 5 min before the start of the task, it significantly 
altered choice behavior (Fig. 3.3).  Overall ANOVA revealed significant main effects of 
group [F(1,280) = 18.3, p < 0.001] and delay [F(4,280) = 50.8, p < 0.001], as well as a 
group x delay interaction [F(4,280) = 3.20, p < 0.01].  Subsequent analysis of within-
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group AMPH effects using a two-way ANOVA and post-hoc tests revealed dose-
dependent changes in LCRs [dose: F(3,84) = 3.28, p < 0.05], with a trend for a dose x 
delay interaction [F(12,84 = 1.81, p = 0.06].  As shown in Fig. 3.3A for LCRs, 1.0 mg/kg 
AMPH decreased choice of the large reward compared to that observed following 
vehicle injection.  The most robust effect was at the 20-s delay.  There were no 
significant effects of any of the tested AMPH doses on choice behavior in HCRs.  For 
number of trial omissions, overall ANOVA revealed a significant main effect of dose 
[F(3,280) = 10.6, p < 0.001] and a delay x dose interaction [F(12,280) = 3.05, p < 
0.001].  Subsequent analysis revealed that the 1.0 mg/kg dose of AMPH was 
significantly different from vehicle, but only in HCRs and only at the 20-s delay (Fig. 
3.3C).   
 The latency to nosepoke for the presentation of levers, as well as latency to 
respond on a lever, was altered to a modest extent by AMPH.  For these analyses, data 
were collapsed across delay because latencies remained relatively stable across the 
session.  We observed significant main effects of dose for both measures [nosepoke 
latency: F(3,42) = 6.13, p < 0.001; lever press latency: F(3,42) = 2.94, p < 0.05].  As 
shown in Table 3.1, the 0.3 mg/kg dose significantly decreased response latencies in 
LCRs.  The number of nosepoke responses that rats made during periods when food 
pellets were not available—during ITIs and during delays following responses on the 
large reward lever—was not significantly different between LCRs and HCRs following 
vehicle injection or after AMPH treatment (data not shown).          
 
Effects of 8-OH-DPAT on delay-discounting 
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When 8-OH-DPAT was administered 5 min before the start of the task, it 
significantly reduced choice of the large reward, with a relatively greater effect in LCRs 
(Fig. 3.4A).  An overall ANOVA revealed significant main effects of group [F(1,280) = 
34.2, p < 0.001], dose [F(3,280) = 12.3, p < 0.001], and delay [F(4,280) = 37.0, p < 
0.001].  Subsequent analysis of 8-OH-DPAT within groups revealed that the two highest 
doses significantly decreased choice of the large reward in LCRs, and in particular, at 
the 0-, 10-, and 20-s delays.  The effect of 1.0 mg/kg 8-OH-DPAT was also significant at 
the 40-s delay.  In HCRs, all three doses reduced responding on the large reward lever, 
but this effect was only significant at the 0-s delay (Fig. 3.4B).  The changes in choice 
behavior produced by 8-OH-DPAT were associated with increases in trial omissions, 
which were evident in both groups at the 0.6 and 1.0 mg/kg doses (Fig. 3.4C).  
Statistical analysis revealed a trend for a main effect of dose in LCRs [F(3,84) = 2.57, p 
= 0.08] and a significant main effect of dose [F(3,84) = 4.99, p < 0.01] and a delay x 
dose interaction [F(12,84) = 3.93, p < 0.001] in HCRs.   
 The latency to nosepoke for the presentation of levers, as well as to respond on 
a lever, was also altered by 8-OH-DPAT.  Similar to the analysis of AMPH effects, these 
data were collapsed across delay because latencies remained stable across the 
session.  We found significant main effects of dose for both measures [nosepoke 
latency: F(3,42) = 8.14, p < 0.001; lever press latency: F(3,37) = 6.31, p < 0.05], with 
the 0.6 and 1.0 mg/kg doses having significant effects compared to vehicle injections 
(Table 3.1).  There was no significant effect of 8-OH-DPAT on the total number of 
nosepoke responses that rats made during periods when food pellets were not 
available. 
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Discussion 
A primary goal of this study was to investigate a potential overlapping 
relationship between individual differences in the initial sensitivity to cocaine-induced 
behavior and impulsive choice.  Using a delay-discounting operant procedure, we 
observed baseline differences in impulsive choice behavior in rats with disparate 
locomotor responses to 10 mg/kg cocaine in an open-field arena.  Specifically, HCRs 
showed a greater sensitivity to delay, and thus behaved more impulsively, compared to 
LCRs.  When AMPH was administered prior to delay-discounting sessions, we found 
that the highest dose tested (1.0 mg/kg) increased impulsive choice in LCRs without 
influencing the number of trial omissions.  None of the tested doses had a statistically 
significant effect on impulsive choice in HCRs, although the highest dose significantly 
increased trial omissions.  When rats were tested for the effects of 8-OH-DPAT, which 
occurred one week after the last AMPH test session, we found significant increases in 
impulsive choice in both phenotypes, although HCRs were only affected at the 0-s 
delay.  Taken together, our results suggest that initial sensitivity to the locomotor effects 
of cocaine can be used to predict subsequent behavior in a delay-discounting task that 
examines trait behavior associated with drug use and dependence (Dalley et al., 
2007a).  Furthermore, they show that drugs previously shown to alter impulsive choice 
in rats (e.g., Cardinal et al., 2000; Evenden and Ryan, 1996, 1999; van Gaalen et al., 
2006; Winstanley et al., 2005) have differential effects in LCRs compared to HCRs.   
While ours is the first published study to assess the relationship between 
individual differences in cocaine-induced locomotion and impulsivity, several studies 
have investigated individual differences in response to novelty as a predictor of 
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impulsive behavior (Bardo et al., 2006; Dellu-Hagedorn, 2006; Stoffel and Cunningham, 
2008).  For example, Stoffel and Cunningham (2008) examined the relationship 
between locomotor activation induced by exposure to an inescapable novel 
environment and impulsive behavior in a differential reinforcement of low rates of 
responding (DRL) task.  They found that novelty phenotype was predictive of the 
behavioral inhibition displayed, such that the high novelty responders (HRs) were more 
impulsive than low novelty responders (LRs).  In addition, HRs and LRs were equally 
sensitive to cocaine-induced increases in impulsivity.  Although it was not the focus of 
the present study, we analyzed the relationship between novelty responses and 
impulsivity by re-characterizing our rats as LRs or HRs based on their locomotor 
behavior during the first 30 min of the habituation period on their first open-field test.  
We found no significant differences in delay-discounting behavior in LRs and HRs (data 
not shown).  Notably, the lack of overlap between the novelty and cocaine response 
phenotypes has been described previously in male Sprague-Dawley rats (Gulley et al., 
2003; Gulley, 2007), and suggests the LCR/HCR classification is somewhat distinct 
from one based on novelty and may be mediated by different neural mechanisms.  It is 
also noteworthy that different methods of assessing impulsive behavior in rats (e.g., 
delay-discounting compared to DRL tasks) are likely to be focusing on particular 
aspects of impulsivity, and the neural mechanisms of impulsive behavior are not likely to 
be identical (Evenden, 1999; Winstanley et al., 2006a).  
AMPH had differential effects on impulsive choice in our tests, with increases 
observed in LCRs and no effect observed in HCRs.  These results were somewhat 
surprising given previous reports that suggested AMPH, at the doses tested here, 
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decreases impulsivity (Barbelivien et al., 2008; Cardinal et al., 2000; deWit et al., 2002; 
Winstanley et al., 2003; van Gaalen et al., 2006).  However, AMPH’s effects on delay-
discounting behavior are not unequivocal; it has been shown to increase (Evenden and 
Ryan, 1996; Cardinal et al., 2000) or have little to no effect on impulsive choice 
(Barbelivien et al., 2008; Uslaner and Robinson, 2006).  One factor that has been 
suggested as a potential contributor to these inconsistent results is differences in the 
baseline level of delay-discounting that rats exhibit.  In a previous study (Winstanley et 
al., 2003), AMPH was most effective at altering task behavior in rats that expressed a 
high baseline level of impulsivity.  In our study, however, HCR rats showed the greatest 
sensitivity to delay at baseline and AMPH had no significant effect on their choice of the 
large reward across delays.  These results are consistent with those from a recent study 
by Barbelivien et al. (2008).  AMPH did increase the number of trial omissions at the 
highest dose, which is consistent with an enhanced sensitivity to AMPH-induced 
disruptions in motor behavior that might be expected in rats with high locomotor 
responses to cocaine.  Interestingly, in that same study (Winstanley et al., 2003), the 
authors reported that AMPH’s effects on impulsive choice were attenuated in a group of 
rats that were depleted of their forebrain 5-HT levels.  Thus, impulsive choice might not 
only depend on baseline levels of impulsivity, but also on intact neurotransmitter 
systems.  The results from the present study do offer some insight into the 
consequences of the neurobiological differences between LCRs and HCRs.  Because 
the DAT is a primary pharmacological target of AMPH, and alterations in DA signaling 
are important for behavior in the delay-discounting task (Floresco et al., 2007; van 
Gaalen et al., 2006), the differential effects we observed for AMPH in LCRs compared 
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to HCRs are a likely reflection of known differences in DAT function between these 
phenotypes (Sabeti et al., 2003; Briegleb et al., 2004).  Importantly, impulsive choice 
behavior may be influenced by an interaction between DAergic and 5-HTergic function 
(Winstanley et al., 2005, 2006b), and this could be relevant for differences in choice 
behavior between LCRs and HCRs.  
Direct stimulation of the 5-HT1A receptor through administration of the selective 
agonist 8-OH-DPAT reduced responding for the large reinforcement in both groups, with 
LCRs choosing it less frequently across a wide range of delays (10-40 s) at both the 0.6 
and 1.0 mg/kg doses.  The effect in HCRs was seen at all three tested doses, but only 
when there was no delay in reinforcement delivery.  Increases in impulsive choice 
following 1.0 mg/kg 8-OH-DPAT have been reported previously (Winstanley et al., 
2005), and this effect is partly related to the drug’s activation of both postsynaptic 5-HT 
receptors and somatodendritic autoreceptors.  The lack of effect at the 10-60 s delays in 
HCRs may be due to a floor effect as these rats were already demonstrating steep 
delay discounting curves (i.e., highly impulsive) at baseline.  Additional studies will be 
necessary to determine if differences in 5-HT systems between LCRs and HCRs 
contribute to some of the differences in behavior in these phenotypes.  Noteworthy in 
this regard are a number of recent studies highlighting the importance of 5-HT systems 
in cocaine-induced locomotor activity (Bubar and Cunningham, 2006; Carey et al., 
2001, 2005; Liu and Cunningham, 2005), as well as timing processes (Ho et al., 2002) 
and sensitivity to delayed reinforcement (Mobini et al., 2000; Wogar et al., 1993).  It will 
also be important to determine if the effects of 8-OH-DPAT on delay-discounting are 
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influenced by changes in other behavioral processes, such as altered motivation for 
feeding or disrupted motor processes.         
After the conclusion of the final delay-discounting sessions – which was 
approximately three months after the first cocaine injection was given – rats were 
retested in the open-field with 10 mg/kg cocaine.  The behavior of LCRs was not 
significantly different on retest compared to the first test, whereas HCRs exhibited a 
relative decrease in cocaine-induced locomotor activity. The stability of the LCR 
phenotype, and the apparent tolerance evident in HCRs, is consistent with a previous 
study where LCRs and HCRs were retested following a seven day period where they 
were given extensive habituation to the testing environment (Gulley et al., 2003).  In the 
present study, it is possible that either the AMPH and/or 8-OH-DPAT treatment in the 
context of the delay-discounting task had an effect on subsequent locomotor behavior in 
the open-field retest.  This is unlikely for several reasons.  First, the retest was given a 
week after the last drug treatment to prevent any carry-over effects.  Second, 
administration of these drugs at low to moderate doses tends to potentiate locomotor 
activity when given alone or prior to cocaine (Carey et al., 2002, 2004; Chen and Reith, 
1995; De La Garza and Cunningham, 2000; Herges and Taylor, 1998; Müller et al., 
2003; Schenk et al., 1991).  Lastly, the highest dose of 8-OH-DPAT has been shown to 
inhibit locomotor activity (Przegalinski and Filip, 1997), but this was true only when it 
was co-administered with cocaine.  Thus, at this point, we speculate that the differences 
in locomotor activity on retest reflect distinct underlying neural adaptations that may be 
pre-existing and relate to findings from rats with a history of repeated drug exposure.  
This hypothesis is based on findings that behavioral sensitization is evident in LCRs, 
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while HCRs show a lack of sensitization (Sabeti et al., 2003; unpublished observations).  
Interestingly, Ben-Shahar et al. (2005) reported differential behavioral responses to the 
locomotor stimulating effects of cocaine in animals who were previously given short or 
extended access to self-administer cocaine.  Specifically, they reported sensitization in 
rats with short access compared to tolerance in those with extended access.  This 
escalation model of repeated drug self-administration is associated with addictive 
behaviors shown in humans (Ahmed and Koob, 1998; Ben-Shahar et al., 2004, 2005).  
In summary, we found that two traits previously associated with those who abuse 
cocaine and other drugs, namely initial sensitivity to drug-induced behavior and 
impulsivity, are closely related to one another in a rat model of these behaviors.  These 
findings highlight the importance of studying individual differences, especially in the 
context of pre-disposing traits that overlap with other behaviors that can potentially be 
related to the vulnerability for drug dependence.  It is possible that the disparate drug-
induced locomotor responses and ensuing differences in delay-discounting behavior are 
the result of distinct underlying neural mechanisms.  Future studies should focus on 
how pre-existing traits interact with drug-induced neuroadaptations, as they have the 
potential to provide a better understanding of the underlying neurobiological 
mechanisms contributing to individual differences in drug abuse potential.  It will also be 
important to determine how differential sensitivity to cocaine predicts behavior in other 
experimental paradigms that assess other aspects of the multifaceted trait of impulsivity, 
such as the five-choice serial reaction time task, differential reinforcement of low rate of 
responding, or fixed consecutive number schedule. 
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CHAPTER 4: DIFFERENTIAL VULNERABILITY TO AMPHETAMINE-INDUCED 
DEFICITS IN A WORKING MEMORY TASK: THE EFFECTS OF EXPOSURE 
METHOD, AGE, AND INITIAL PSYCHOSTIMULANT SENSITIVITY3 
 
 
Abstract 
While amphetamine (AMPH) exposure is known to cause long-term changes in 
drug-induced locomotor behavior (i.e., sensitization), the direct relationship between 
cognitive dysfunction and chronic psychostimulant abuse is unclear.  Since recreational, 
and more recently therapeutic, use of AMPH is often initiated during adolescence, this 
period of dramatic structural and functional development may be linked to an increased 
predisposition to drug-induced deficits.  In addition, pre-existing differences in the acute 
response of a psychostimulant’s behavioral effects may be intensified by subsequent 
drug exposure and predictive of long-lasting changes in cognitive function.  To address 
these issues, we first classified adolescent and adult male Sprague-Dawley rats as low 
or high cocaine responders (LCRs and HCRs, respectively) based on their acute 
locomotor response to 10 mg/kg (i.p.) cocaine in an open-field arena.  The rats were 
then exposed to either saline or AMPH using an intermittent (INT) or escalation-binge 
(E-B) exposure method, which have been reported to produce distinctive behavioral 
profiles of sensitization and tolerance, respectively. Rats in the INT group were given 
saline or 3 mg/kg AMPH (i.p.) every other day for 19 days; those in the E-B groups were 
given saline or escalating doses of AMPH (1-8 mg/kg, i.p.) over 4 days, followed by a 
single binge treatment (saline or 8 mg/kg AMPH, every 2 hr for 8 hr).  Adolescent rats 
                                                 
3
 Some data from this chapter appeared in the journal Behavioral Brain Research as Sherrill LK, 
Stanis JJ, Gulley JM (2013) Age-dependent effects of repeated amphetamine exposure on 
working memory in rats. Jan 3; 242C:84-94.  Data are included with the permission of the 
publisher and is available from http://www.sciencedirect.com and using DOI: 
10.1016/j.bbr.2012.12.044 
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began these treatments on postnatal day (PND) 37 or 41, whereas adult rats began 
these treatments on PND 92 or 96.  After all rats reached adulthood (PND 90 or 123), 
cognitive performance was assessed using an operant-based delayed matching-to-
position (DMTP) and delayed non-matching-to-position (DNMTP) task that is sensitive 
to prefrontal cortex function.  We subsequently measured the effects of acute AMPH 
(0.3-1.25 mg/kg) and the NMDA receptor antagonist, ketamine (5-10 mg/kg), on 
DNMTP performance.  Lastly, we tested for long-lasting effects of pretreatment by 
giving dose-appropriate AMPH challenges one week after the final DNMTP session.  
Repeated AMPH in the INT groups produced sensitization to the drug’s stereotypy-
inducing effects, and this effect was less pronounced in adolescent- compared to adult-
treated rats.  Similarly, adolescents in the E-B group were less sensitive to the 
stereotypy-inducing effects of 8 mg/kg AMPH than adults.  However, adolescents were 
vulnerable to exposure-induced learning and memory impairments, as both INT and E-B 
rats required more sessions to reach criterion at longer delays and showed delay-
dependent deficits.  In contrast, only adult-exposed E-B rats showed delay-dependent 
deficits that persisted through criterion, overtraining, and task reversal (along with 
adolescent-exposed rats in the intermittent treatment group).  Moreover, rats classified 
as LCRs exhibited the greatest delay-dependent impairments.  While AMPH dose-
dependently altered DNMTP accuracy in both age-exposed groups, ketamine induced 
delay-independent effects.  The AMPH challenges, given approximately two months 
after the final pretreatment injection revealed that sensitization was still evident in all 
rats.  Our results suggest that AMPH exposure has long-lasting consequences on 
learning and memory processes.  These deficits are dependent on both the age and 
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method of exposure, as well as individual differences that are related to the disparate 
function of dopamine transporters. 
 
Introduction 
 
AMPH is prescribed at an increasingly alarming rate for therapeutic purposes, 
and is one of the most abused psychoactive drugs in the world (World Drug Report, 
2012).  Both clinical and preclinical studies have revealed that chronic AMPH use is 
associated with deficits in concentration and attentional control, decision-making and 
planning, as well as working memory (e.g., Bechara et al., 1994; McKetin and Mattick, 
1998; Rogers et al., 1999; Ornstein et al., 2000; Ersche et al., 2006).  Such impairments 
in functions are proposed to be mediated by the prefrontal cortex and associated limbic 
circuitry (see Jentsch and Taylor, 1999; Goldstein and Volkow, 2002; Arnsten and 
Rubia, 2012).  While we hypothesize that drug-induced changes in brain function are a 
major contributing factor to the behaviors that characterize drug use and dependence, 
results from human studies make it rather difficult to ascertain whether co-morbid 
personality traits like impulsivity and cognitive dysfunction predate the onset of drug use 
or occur as a consequence of chronic use.  Accumulating evidence from animal studies 
is incongruent.  A few studies suggest that repeated exposure to AMPH leads to chronic 
deficits (Castner et al., 2005), while more report that AMPH exposure did not lead to 
impairments in working memory (Featherstone et al., 2008), spatial learning or memory 
(Russig et al., 2003), or delayed alternation (Stefani and Moghaddam, 2002).       
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Previously, we showed that adaptations in the locomotor response to AMPH can 
be dissociated from drug-induced adaptations in cognitive behavior when an intermittent 
treatment method of AMPH exposure is utilized (Stanis et al., 2008b).  This is important 
because numerous studies have demonstrated that intermittent treatment with 
psychostimulants like AMPH leads to plasticity in the mPFC (Robinson and Kolb, 2004; 
Kalivas, 2007) and these changes have been hypothesized as important substrates for 
the long-lasting adaptations in behavior observed in human psychostimulant abusers 
(Everitt and Wolf, 2002; Robbins and Everitt, 2002; Jones and Bonci, 2005; Kauer and 
Malenka, 2007).  Thus, the method, or pattern, of drug exposure is an important factor 
to consider.  An AMPH escalation-binge exposure method (adapted from Segal and 
Kuczenski, 1997) more closely approximates the pattern of use by human AMPH 
abusers and might contribute to the development of AMPH-induced adaptations in 
cognitive behavior.  Escalated self-administration of cocaine has been shown to 
produce locomotor tolerance to its stimulant effects on locomotor activity (Ben-Shahar 
et al., 2005), in contrast to the vast studies showing behavioral sensitization.  
Interestingly, cognitive deficits have been reported in rats trained to self-administer 
cocaine, but only in those found to escalate their intake over time (George et al., 2008).  
Thus, dose escalation should not be overlooked in treatment paradigms, and several 
studies underscore a translational relevance (Segal et al., 2003; O’Neil et al., 2006; 
Kuczenski et al., 2007; Belcher et al., 2008; Izquierdo et al., 2010). 
Another factor that might contribute to AMPH’s ability to induce cognitive 
dysfunction is the age at which exposure occurs.  AMPH use typically starts during 
adolescence (DeWit et al., 1997), when the prefrontal cortex is going through normal 
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development changes (Cunningham et al., 2002; Casey et al., 2005; Markham et al., 
2007).  Early exposure to AMPH could lead to deleterious effects in the later expression 
of behavior and cognitive function.  One study showed that even AMPH exposure given 
repeatedly at low doses produced changes in spine density in the mPFC (Diaz Heijtz et 
al., 2005).  Unfortunately, they only reported evidence on the structural organization and 
not on any behavioral correlates.  Several reviews have outlined the importance of 
studying adolescence at the behavioral (Laviola et al., 1999; Spear, 2000; Laviola et al., 
2003) and neural systems (Andersen, 2003; Ernst and Fudge, 2009; Brenhouse and 
Andersen, 2011) levels. 
A third factor that might overlap with AMPH-induced changes is the initial 
sensitivity to a psychostimulant.  In humans, individual differences in sensitivity 
predicted greater use and dependence (Davidson et al., 1993; Lambert et al., 2006).  
Pre-existing differences in the acute response of a psychostimulant’s behavioral effects 
may be intensified by subsequent drug exposure and predictive of long-lasting changes 
in cognitive function.  It has been shown previously that rats classified by a single 
injection of cocaine can be a useful model for studying individual differences.  A number 
of studies have shown that the cocaine-induced phenotype can be used to predict a 
number of behaviors, such as conditioned place preference (Allen et al., 2007), 
intravenous cocaine self-administration (Mandt et al., 2009), drug-discrimination (Klein 
and Gulley, 2009), and impulsive choice behavior (Stanis et al., 2008a).  The primary 
target underlying the individual differences is the function of dopamine transporters 
(DATs) in the dorsal striatum and nucleus accumbens (Sabeti et al., 2002, 2003) and 
not to pharmacokinetic factors (Gulley et al., 2003).  While no studies have addressed 
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neural changes outside of the dorsal and ventral striatum, given the extensive 
behavioral changes, it is not implausible to assume parallel changes in other neural 
systems, like the prefrontal cortex.           
The primary aim of the current study was to look at the long-lasting effects of 
repeated AMPH exposure (intermittent and escalation-binge schedules) on locomotion 
and cognitive function in subjects exposed during adolescence or adulthood.  This is 
important because very few studies carefully examine both the locomotor profiles and 
cognitive behavior in the same animals after chronic drug treatment.  In addition, by 
classifying rats based on their initial sensitivity to a psychostimulant, we wanted to 
examine whether the acute response could be predictive of any lasting cognitive 
dysfunction.  Working memory was assessed using a delayed matching-to-position 
(DMTP) task has been shown consistently to be highly sensitive to changes in mPFC 
function (Fuster and Alexander, 1971; Kolb, 1990; Goldman-Rakic, 1995; Dias and 
Aggleton, 2000; Brown and Bowman, 2002).  After rats learned the task, we also 
examined reversal learning by switching to a delayed non-matching-to-position 
(DNMTP) task and then examined whether acute treatment with AMPH or ketamine, an 
NMDA antagonist, altered memory performance.  Lastly, all rats were given a challenge 
injection of AMPH (intermittent: 3.0 mg/kg; escalation-binge: 8.0 mg/kg) to determine if 
long-lasting changes in locomotor activity were evident.   
 
Methods 
Subjects.   The adult-exposed males (n=55) were Sprague-Dawley rats obtained 
from Harlan (Indianapolis, IN, USA) on postnatal day (PND) 75 and housed individually 
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upon arrival.  The adolescent-exposed rats (n=50) were bred in our animal facility from 
stock rats obtained from Harlan.  Males were group-housed (2-3 per cage) following 
weaning at PND 25 and were housed individually after PND 85.  They were maintained 
on a 12:12 hr light/dark cycle (lights on at 08:00) with experimental sessions conducted 
between 08:30 and 19:30 hr.  Rats were handled three times at 15-min intervals prior to 
being used in experiments (PND 32-34).  Food was available ad libitum before the rats 
were housed separately and again when they completed operant training and testing.  
During operant training and testing, rats were food restricted to approximately 85% of 
their free feeding weight.  Water was always available ad libitum.  All experimental 
procedures were approved by the IACUC at the University of Illinois, Urbana-
Champaign and were consistent with the Principles of Laboratory Animal Care. 
Apparatus.  Locomotor activity was measured in an open-field chamber that 
consisted of a transparent, Plexiglas box (40.6 x 40.6 x 40.6 cm) surrounded by 
photobeams (Coulbourn Instruments; Allentown, PA).  Each apparatus was connected 
to a computer operating software (TruScan, v. 2.01; Coulbourn Instruments) that 
recorded all horizontal and vertical beam breaks (100 ms sampling rate).  The horizontal 
beam breaks, or coordinate changes, were converted into distance traveled (cm).  The 
chambers were individually contained inside sound-attenuating cubicles (76 x 80 x 63 
cm).  Each cubicle contained a speaker (76 mm dia.) fixed to one wall, two ceiling-
mounted white lights (4 W) for dim illumination, and a ceiling-mounted camera between 
the two lights.  White nose (70 dB) was played continuously through the speakers when 
rats were in the testing room.   
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Operant behavior was monitored in standard operant chambers (Coulbourn 
Instruments).  One wall of the chamber contained two retractable levers that were 
positioned on either side of a centrally located food trough.  Infrared detectors were 
used to monitor head entries into the food trough.  White cue lights were located above 
each lever.  A white houselight was located near the top of the chamber on the opposite 
wall. 
Initial behavioral characterization: Locomotor activity in the open-field.  Rats were 
first tested in the open-field on PND35 or PND90.  After a 30-min acclimation period in 
the testing room, rats were placed in the open-field chambers for 90 min.  They were 
then removed from the chamber, injected (i.p.) with (-) cocaine HCl (10 mg/kg) and 
placed back into the chamber for an additional 60 min.  This dose was chosen based on 
previous studies (Sabeti et al, 2002; Gulley et al, 2003; Stanis et al., 2008a) showing 
that it is optimal for inducing the widest range of behavioral responses in male Sprague-
Dawley rats.  After the testing session, rats were returned to the colony room and given 
one day off before being randomly assigned to one of six repeated exposure groups.  
Repeated saline or AMPH treatment.  Rats were randomly assigned to one of six 
groups that received saline or AMPH on an intermittent or escalation-binge schedule 
during adolescence or adulthood.  Rats assigned to the intermittent group were given 
once daily injections (i.p.) of 0.9% saline or 3 mg/kg AMPH, every other day for 20 days 
(10 injections total).  We previously used this procedure to induce long-lasting 
behavioral sensitization (>3 months) in rats exposed during adulthood (Stanis et al., 
2008b).   Injections for the intermittent group began on PND37 (n=8 given saline; n=16 
given AMPH) or PND92 (n=8 given saline; n=19 given AMPH) and ended on PND55 or 
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PND110.  Rats assigned to the escalation-binge group were given three daily injections 
of 0.9% saline or AMPH (i.p.), with the administered AMPH dose increasing 
progressively over four days.  Rats started with 1 mg/kg on treatment day 1 and ended 
on treatment day 4 with 8 mg/kg AMPH.  After a day of no injections, they were given an 
AMPH “binge” where injections of 8 mg/kg were given every 2 hours for a total of 4 
injections (see Table 4.1 for summary).  Two days later, rats were given an initial 
challenge injection of saline or 8 mg/kg AMPH.  Injections for rats in the escalation-
binge treatment group began on PND41 (n=8 given saline; n=18 given AMPH) or 
PND96 (n=7 given saline; n=21 given AMPH) and ended on PND49 or PND104.  All 
injections were either given in an open-field chamber, a testing cage, or the rat’s home 
cage.  After treatment ended, rats remained in their home cage assignment until PND85 
or PND118, when food restriction and operant training began. 
DMTP/DNMTP behavior.  All rats were food deprived (~85%) over a period of 5 
days and then began lever press training on a continuous fixed reinforcement schedule.   
Training on an operant version of the delayed matching to position (DMTP) task 
(adapted from Dunnett, 1985) first consisted of session without delays.  During the no 
delay, daily sessions, each of the 100 trials began with a 5-s ITI with the house light on.  
Lever A or Lever B was randomly presented, with equal probability, and the rat had 10 s 
to press the presented lever or else the trial ended and the lever retracted, the house 
light turned off, and a new trial began.  Upon a successful lever press, the lever would 
retract and the magazine light turned on to cue the rat to the food trough.  After a nose 
poke into the trough, the previously presented lever is presented again, and the rat 
received a food pellet reinforcement if the same lever was pressed.  In this step, the rat 
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had no choice after nose poking but to choose the sample lever because only the 
sample lever was presented.  In the next daily session, the nose poke led to both levers 
being extended.  Each session in this stage and the following stages contained 112 
trials.  Now, the rat must select the lever that was originally presented in order to 
receive a reward.  Responses on the opposite lever were not reinforced and instead 
resulted in a 5-sec timeout period. Once the rat achieved 85% correct or better 
performance on consecutive sessions, the next phase of training began.  During the 
next phase, delays were introduced between the nose poke after the “sample” lever and 
the choice presentation of the levers.  This essentially forced the rat to remember which 
lever was presented earlier in order to receive food reinforcement.  Delay intervals were 
randomly selected on each trial; the first set of delays were short (consisting of 0, 1, 2, 
3, 4, 5, and 6s).  Performance of 85% correct or greater on consecutive sessions 
allowed the progression onto the next delay block of medium length (0, 1, 2, 4, 8, 12, 
and 16s), after which the final set of long delays was introduced (0, 2, 4, 8, 12, 18, and 
24s).  This delay progression was chosen to avoid response extinction, because longer 
delays have the potential to disrupt performance if the task has not been acquired.  
Upon reaching performance of 85% correct or higher for consecutive sessions, rats 
were overtrained for 5 additional sessions.  All rats were then switched to the opposite 
non-matching rule (delayed non-matching to position).  This final reversal phase was 
identical to the DMTP version, except the rewarded lever became the opposite of the 
sample.  This step, along with repeated nosepoke responses during delay phases, 
alleviated the adoption of positional mediating strategies.    
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 Following the last training session (second session of 85% correct or higher), the 
effects of AMPH and ketamine on task behavior were assessed in two testing blocks.  
For the first testing block, rats were given injections of vehicle (saline; 1 ml/kg, i.p.) or 
AMPH (0.3, 0.75, and 1.25 mg/kg, i.p.) 5 min before they were placed in the operant 
chamber for a test session.  Injections were given over 5 consecutive sessions (i.e., 
SDDDS, where S = saline and D = drug).  The order of drug doses was chosen based 
on a Latin square design, with a particular order assigned to each rat randomly.  Rats 
were given a day off before starting the second block of injections.  For these tests, 
ketamine (5, 7.5, 10 mg/kg, i.p.) was given 10 min prior to placement in the operant 
chambers.   
 Open-field AMPH challenge.  After their final operant session (> PND240), rats 
were given access to food ad libitum.  One week later, they were challenged with the 
dose respective to their original treatment group.  Thus, rats in the intermittent group 
were given a 3.0 mg/kg i.p. AMPH injection, while rats in the escalation-binge group 
were given an 8.0 mg/kg AMPH injection.  The saline rats were equally divided between 
groups and given either 3.0 or 8.0 mg/kg AMPH.  
Drugs.  The (-) cocaine HCl used in this study was obtained from NIDA (RTI 
International; Research Triangle Park, NC).  d-Amphetamine sulfate was obtained from 
Sigma-Aldrich (St. Louis, MO).  Ketamine HCl was obtained in a 100 mg/ml injectable 
solution (Ketaset; Pfizer Animal Health; Fort Dodge, IA) and diluted with sterile saline to 
appropriate concentrations for injections.  Cocaine and AMPH were dissolved in sterile 
saline (0.9% NaCl), with dosages calculated based on the weight of the salt.  All 
injections were given at a volume of 1 ml/kg. 
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Data analyses.  All analyses were conducted using SAS 9.3 (SAS Institute, Inc.; 
Cary, NC) and SQL Server 2005 Developer (Microsoft; Seattle, WA).  All graphs show 
group means ± SEM.  Cocaine-induced locomotor activity in the open-field was 
assessed by determining the cumulative activity during the first 30-min following 
injection. Here and as in previous studies (Gulley et al., 2003; Gulley, 2007; Stanis et 
al., 2008a), rats with activity scores in the lower half of the population distribution were 
designated LCRs and those in the upper half were designated HCRs.  LCRs and HCRs 
were assigned to treatment groups to ensure an equal representation across groups.  
The statistical significance of group differences in cocaine-induced activity was 
determined using two-way ANOVA (class x age).   
For analysis of locomotor behavior in the intermittent and escalation-binge 
groups, two methods were used: one quantitative and one semi-quantitative.  
Ambulatory distance was quantitatively measured by photobeam breaks and was 
recorded as the total horizontal distance traveled minus periods absent of locomotion 
when the animal exhibited a repetitive behavior.  In order to accurately measure the 
range of behaviors, stereotypy was semi-quantitatively measured for 30 second 
intervals every 5 minutes by a blind scorer from recorded videos.  Stereotypy intensity 
was rated as mild (1), moderate (2), or intense (3) and multiplied by the duration 
(seconds spent exhibiting the scored behavior), giving a scoring range from 0-90.  
Because a time-course of AMPH-induced behavior (for ambulation and stereotypy) for 
the intermittent schedule in adults was previously published (Stanis et al., 2008b), 
ambulation data were summed over the 60 min session, while stereotypy data were 
averaged.  Data were analyzed using a repeated two-way ANOVA, with treatment day 
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as within-subjects factor and treatment group as the between-subjects factor.  Data 
from the escalation-binge groups were analyzed using a repeated two-way ANOVA 
(binge-run: treatment group x time) or three-way ANOVA (treatment group x session x 
time).  Follow-up analyses of significant interactions were performed with one- or two-
way ANOVA and Tukey post hoc tests.  Missing values were excluded from analyses. 
For analyses of operant-task behavior, several measures were used.  The 
progression of task performance was monitored by the number of sessions required to 
reach criterion at each of the delay blocks.  Working memory was assessed by 
calculating the mean percentage of correct choices across delays for the long delay-
block sessions.  In order to examine delay-dependent changes over time, percent 
correct was compared for the first two sessions in the long delay-block and for the first 
two sessions a rat met performance criterion.  In order to figure out an animal’s 
accuracy between two levers, index Y was also calculated according the following 
formula; 
Index Y = | p (cor | A) - p (cor | B)| 
                  p (cor | A) + p (cor | B) 
 
where p (cor | A/B) is the probability of making a correct response when the sample was 
presented as lever A or B, respectively.  Data were analyzed with repeated-measures 
ANOVAs (treatment group as the between-subjects factor and delay and delay block as 
within-subjects factors).  When appropriate, Tukey post hoc tests were used. 
 Performance following AMPH and ketamine drug challenges was assessed by 
calculating mean percent correct and the number of trials omitted during each session.  
These measures were analyzed with repeated-measures ANOVAs with treatment group 
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as the between-subjects factor, and dose as the within-subjects factor.  Tukey post-hoc 
tests were used.  In all tests, p values less than 0.05 were considered significant.  
 
Results 
Locomotor behavior 
In both adolescent (PND35) and adult rats (PND90), the first exposure to 10 
mg/kg cocaine resulted in disparate locomotor activity that could be described by 
separating rats into LCRs and HCRs (Fig. 4.1).  This difference was statistically 
significant [main effect of class: F(1,101) = 158, p<0.001].  Adolescent LCRs exhibited 
on average 66% less cocaine-induced activity compared to that observed in HCRs, 
whereas adult LCRs showed 50% less cocaine-induced activity compared to HCRs.  In 
general, adolescent rats showed 35% less ambulation than adults [main effect of age: 
F(1,101) = 46.1, p<0.001].  
As shown in Fig. 4.2, AMPH produced significant changes in ambulation and 
stereotyped behavior following the first (T1) and tenth (T10) injections.  These changes 
in activity were also evident when an AMPH challenge was given at the conclusion of 
operant testing, which occurred approximately four months after pre-treatment for rats 
exposed during adolescence and three months for rats in the adult-exposed group.  
Separate two-way ANOVAs revealed significant interactions between group and 
treatment session for ambulation [F(6,92) = 22.2, p<0.001] and stereotypy [F(6,93) = 
7.69, p<0.001].  Compared to saline-treated controls, rats in both the adolescent- and 
adult-exposed groups exhibited significant increases in ambulation and stereotypy the 
first and tenth injections with 3 mg/kg AMPH.  For adolescent-exposed rats, ambulation 
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was elevated in a similar magnitude following the first and tenth injections.  However, in 
adult-exposed rats, there was a significant reduction in ambulation following the tenth 
injection compared to the first.  All rats received an injection of 3 mg/kg AMPH during 
the challenge session.  Compared to saline pre-treated controls, adolescent- and adult-
exposed rats displayed less ambulation but greater stereotyped behavior.  Rats in the 
saline pre-treated groups exhibited significant increases in both ambulation and 
stereotypy compared to their last saline session, and these effects were only 
significantly different from stereotyped behavior observed in adult-exposed rats 
following their first AMPH injection (Fig. 4.2B).  Furthermore, both AMPH-exposed 
groups showed enhanced stereotypy compared to their last treatment session (T10), 
but the overall magnitude of the stereotypy response was lower in adolescent-exposed 
rats.  Pearson correlation analysis did not reveal any significant relationship between 
distance traveled after cocaine injection and the response to AMPH injections.       
AMPH escalation followed by a high-dose, binge AMPH produced episodes of 
intense, focused stereotypy.  As shown in Fig. 4.3, ambulatory activity was measured 
during the binge session, where four injections were given, once every two hours.  After 
a maximal level of stereotyped behavior was observed, the amount of ambulation 
increased.  A two-way repeated measures ANOVA revealed a significant interaction 
between treatment group and time [F(93,1271) = 2.86, p<0.001].  During the last 30 
minutes of each binge injection, adolescent-exposed rats showed a significant increase 
in ambulation compared to adult-exposed rats.  In addition, rats in the adolescent-
exposed group showed maximal ambulation during the final 15 minutes (at the 480 min 
mark), compared to the previous three injections (Fig. 4.3).  
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After the binge session, rats were given one day off before a challenge injection 
was administered in the open-field (8 mg/kg AMPH).  As shown in Fig. 4.4, a high dose 
injection produced significant changes in ambulation and stereotypy.  Separate three-
way ANOVAs revealed significant interactions between group, treatment session, and 
time for ambulation [group x treatment session: F(3,1552) = 82.6, p<0.001; three-way: 
F(45,1552) = 2.41, p<0.001] and for stereotypy [group x treatment session: F(3,912) = 
75.9, p<0.001; three-way: F(45,912) = 1.57, p=0.076].  While the pattern of ambulation 
was very similar between age groups, adolescents showed a rapid decrease starting 
180 minutes post-injection (Fig. 4.4A).  This decrease was associated with a rapid 
decrease in stereotypy (Fig. 4.4B).  After the final challenge, which occurred 
approximately three months after the last injection, ambulation was greatly reduced in 
both age-exposed groups, compared to the first challenge.  Once again, the reduction in 
ambulation was associated with an increase in intense, focused stereotypy over a much 
longer time span.  While the stereotypy response was almost identical during the final 
challenge session, compared to the first challenge, the response in adolescent-exposed 
rats was enhanced to a greater extent.      
 
Delayed Matching to Position Behavior 
 Prior exposure to AMPH altered DMTP behavior (Fig. 4.5-4.7).  While all rats 
learned the task, some rats required more sessions to reach criterion (Fig. 4.5).  Only 
adult-exposed rats in the escalating-binge group showed impairments in acquiring the 
knowledge of how to perform the task (matching without delays; Fig. 4.5B).   After 
delays were introduced, adolescent-exposed rats in the intermittent group and adult-
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exposed rats in the escalating-binge group were most affected during the long delay 
and reversal (DNMTP) blocks.  That is, the groups took longer (needed more sessions) 
than saline-treated animals to reach criterion.  As shown in Fig. 4.5, the deficits were 
dependent on treatment group [F(5,99) = 8.45, p<0.001] and training phase [F(4,394) = 
115, p<0.001].  The interaction between group and phase was not significant (p>0.05).  
Pearson correlation analysis did not reveal any significant relationship between distance 
traveled after cocaine injection and learning the task rules.   
Significant delay-dependent impairments in DMTP behavior were observed in 
both adolescent- and adult-exposed rats during the first two sessions of the long delay 
block (Fig. 4.6 A-B).  Two-way repeated measures ANOVA revealed significant main 
effects of treatment group [F(5,99) = 10.6, p<0.001] and delay [F(6,594) = 211, 
p<0.001], with a significant interaction [F(30,594) = 8.45, p<0.05].  More deficits were 
observed in the adolescent-treated rats, specifically at 8 and 12 s in the escalation-
binge treatment group, and at 8, 12, 18, and 24 s in the intermittent treatment group, 
when compared to saline-treated rats.  In contrast, the escalation-binge adult-exposed 
rats showed significant impairments at 12, 18, and 24 s; whereas, the intermittent group 
only showed a significant difference at 18 s.  Working memory performance was 
markedly improved during the two sessions when criterion was met (Fig. 4.6 C-D).  
Two-way repeated measures ANOVA revealed significant main effects of treatment 
group [F(5,99) = 3.76, p<0.01] and delay [F(6,594) = 297, p<0.001], but no significant 
interaction (p>0.05).  Deficits persisted in the intermittent, adolescent-exposed group 
(24 s), and in the escalation-binge, adult-exposed group (18 and 24 s).  
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When working memory performance data were analyzed according to their 
cocaine response groups, the deficits in both adolescent- and adult-exposed groups 
were largely found in LCRs (Fig. 4.7).  Separate two-way repeated measures ANOVAs 
revealed significant main effects of treatment group [LCRs: F(5,44) = 9.43, p<0.001; 
HCRs: F(5,49) = 5.37, p<0.001] and delay [LCRs: F(6,264) = 113, p<0.001; HCRs: 
F(6,294) = 97.0, p<0.001], with a significant interaction for LCRs [F(30,264) = 1.49, 
p<0.05] and not HCRs (p>0.05).  LCRs in the intermittent, adolescent-exposed group 
showed the most deficits, ranging from 4-24 s (Fig. 4.7A).  Adult-exposed LCRs in the 
intermittent and escalation-binge groups showed deficits from 12-24 s (Fig. 4.7B).  
HCRs, on the other hand, regardless of age or method of exposure, showed no delay-
dependent impairments compared to saline-treated controls (Fig. 4.7 C-D).  While not 
significant, escalation-binge, adult-exposed rats showed a trend for differences at very 
short delays (0-8 s) compared to saline controls.    
None of the groups differed from each other (p<0.05) on measures of general 
responsivity: latency to respond to the sample lever, number of nosepokes during the 
delays, number of omissions, or in index y, a measure of positional strategy (data not 
shown).  
 When rats met performance criterion on DNMTP, they were tested for their 
response to acute doses of AMPH or ketamine (data not shown).  While AMPH dose-
dependently altered DNMTP accuracy in both age-exposed groups [main effect of dose: 
F(3, 15) = 22.0, p<0.001], ketamine induced delay-independent effects (NS main effect 
of dose, p>0.05).  Neither drug was found to alter performance between groups (NS 
main effect of treatment group, p>0.05).      
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Discussion 
 
Chronic AMPH exposure has long-lasting effects on locomotor behavior and 
cognitive function that are dependent on both age and method of drug exposure.  Here, 
we report evidence for a dissociation between the robustness of the locomotor response 
after repeated AMPH exposure and ensuing cognitive deficits.  That is, while adolescent 
rats were less sensitive to the stereotypy-inducing effects of both an intermittent and 
escalation-binge method, they were more vulnerable to exposure-induced learning and 
memory impairments.  Only adolescent-exposed rats in the intermittent treatment group 
and adult-exposed rats in the escalation-binge treatment group showed delay-
dependent deficits that persisted through criterion, overtraining, and task reversal.  
Moreover, the delay dependent deficits in adolescent- and adult-exposed rats could be 
predicted based on their initial sensitivity to a single injection of cocaine.  When rats 
were given an AMPH challenge after the conclusion of their final DNMTP session—a 
procedure that occurred approximately three to four months after their last injection—
the sensitization to AMPH’s stereotypy-inducing effects was still evident and even 
enhanced in both adolescent- and adult-exposed rats.   
After the initial injection of 3.0 mg/kg AMPH, adolescents and adults responded 
similarly in both measures of locomotion and stereotypy.  This is consistent with 
previous studies showing no age-dependent differences in the acute response to AMPH 
(Adriani et al., 1998; Mathews and McCormick, 2007).  After the tenth injection of 3.0 
mg/kg AMPH, a disparate pattern emerged between age groups in stereotypy, such that 
adults displayed more intense stereotypy.  Adolescents did show sensitization to the 
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stereotypy-inducing effects across repeated treatments, but the increase was minor 
compared to adults.  The emergence of reduced sensitivity to repeated AMPH in 
adolescent-exposed, compared to adult-exposed rats, is consistent with prior reports 
(Bolanos et al., 1998; Richetto et al., 2013).  Locomotor sensitization was not observed 
in either groups, and in fact, adults showed a decrease in ambulation after the tenth 
injection.  After the final AMPH challenge, which occurred approximately three months 
after the last injection, sensitization to the stereotypy-inducing effects was still observed 
in both age groups, although the adult-exposed group showed more intense, focused 
stereotypy.   
With respect to the long-lasting sensitization that was observed, it should be 
noted that these rats received additional injections of AMPH (total cumulative dose of 
2.3 mg/kg) and ketamine (total cumulative dose 22.5 mg/kg) across five days of drug 
and vehicle testing in the DNMTP task.  However, the saline controls also had this same 
level of exposure and their responses to the AMPH challenge were similar to the 
response seen in AMPH-exposed rats after their first drug exposure.  Thus, the drug 
challenges during the working memory task are unlikely to account for the persistence 
of sensitization.  Similar long-lasting, stimulant-induced behavior has been observed 
before in adults (Paulson et al., 1991; Stanis et al., 2008b), and in adolescent-exposed 
animals (Richetto et al., 2013). 
A similar pattern of subsensitivity to the stereotypy-inducing effects emerged in 
adolescent-exposed rats in the escalating dose-binge group.  That is, during a binge 
session with four injections (each 8 mg/kg AMPH) spaced two hours apart, after each 
injection, adolescents spent less time in stereotypy and more time ambulating.  These 
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results agree with the only study we know of looking at escalating dose-binge but with 
cocaine (Caster et al., 2005).  Two days following the binge session, rats in the AMPH 
treatment groups were given a challenge injection of 8 mg/kg AMPH and behavior was 
monitored for four hours.  While the pattern of ambulation was very similar between age 
groups, adolescents emerged from intense stereotypy much faster than adults.  After 
the final challenge, which occurred approximately three months after the last injection, 
sensitization to the stereotypy-inducing effects was observed in both age-exposed 
groups.  Interestingly, the sensitization was more pronounced in the adolescent-
exposed group.  To our knowledge, no published studies have described the long-
lasting effects of an escalating dose-binge model of AMPH exposure in adolescent and 
adult animals.  Taken together with the intermittent treatment groups, different patterns 
of sensitization suggest that the neuroadaptations induced by chronic AMPH may be 
unique in adolescents relative to adults.          
We observed age- and method of exposure-dependent differences on learning 
and working memory function.  Rats exposed to 3 mg/kg AMPH during adolescence, 
but not those exposed during adulthood, showed delay-dependent deficits in matching 
during DMTP training.  The working memory deficits were also accompanied by learning 
impairments, as the same rats required more sessions to reach criterion.  Interestingly, 
rats exposed to an escalating-binge schedule of AMPH during adulthood, but not those 
exposed during adolescence, showed the same pattern of learning and memory 
deficiencies.  The observed DMTP deficits are likely the result of distinct neural 
mechanisms, as adolescent-exposed rats showed improvement of memory function, 
unlike the adult-exposed rats.  Thus, we conclude that AMPH caused disruptions in the 
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normal development of the PFC and its dense connections with the hippocampal 
formation for adolescents, whereas adults might be more prone to the neurotoxic effects 
of high-dose AMPH treatment.  Degeneration of pyramidal neurons and interneurons in 
the prefrontal cortex and hippocampus has previously been reported in adult rats 
exposed to escalating dose-multiple binge methamphetamine (Kuczenski et al., 2007). 
After rats completed the matching portion (DMTP), we reversed the rules from 
matching to non-matching in order to examine the effects on inhibition control.  It has 
previously been noted that rats have an innate and preferred strategy to alternate 
responses spontaneously (Richman and Dember, 1986), as is the rule with non-
matching in the DNMTP task.  Interestingly, we found that rats in both intermittent- and 
escalation-binge-exposed groups, regardless of age of exposure, took longer to learn 
the specific rules during the DNMTP phase than during the DMTP phases.  This finding 
is counter to the innate bias, even when working memory requirements were identical.  
Nonetheless, the reversal deficits were most pronounced in the adolescent-exposed 
intermittent treatment and adult-exposed escalation-binge groups and provides 
evidence for a lack of inhibition of a learned response, which has previously been 
shown in animals with selective mPFC damage on a variety of different spatial tasks 
(Granon et al., 1994; Seamans et al., 1995; Ragozzino et al., 1999; Dias and Aggleton, 
2000; Delatour and Gisquet-Verrier, 2000), in humans with PFC damage and 
impairments in the Wisconsin Card Sorting Test (Berman and Weinberger, 1990; Stuss 
et al., 2000), and following repeated psychostimulant treatment (Schoenbaum et al., 
2004; Fletcher et al., 2005; Izquierdo et al., 2010).  
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No significant relationship was found between the initial locomotor response to a 
low dose of cocaine (10 mg/kg) and subsequent locomotor responses to repeated 
AMPH with either exposure method.  While this was somewhat unexpected based on 
previous results suggesting a positive correlation (Sabeti et al., 2003; unpublished 
observations), we expect that the differences are likely a result of administering doses 
that result in intense, focused stereotypy instead of a primary increase in locomotor 
activity.  Fortunately, the initial sensitivity to cocaine could predict certain aspects of 
delay-dependent performance in the DMTP task.  Drug-exposed LCRs were more 
impaired in a delay-dependent manner than HCRs, regardless of age of exposure and 
treatment group.  Because the DAT is a primary pharmacological target of AMPH, and 
changes in DA signaling are important for working memory function (Zahrt et al., 1997; 
Vijayraghavan et al., 2007), the differential effects are possibly a reflection of known 
differences in DAT function between the phenotypes (Sabeti et al., 2003; Mandt and 
Zahniser, 2009).  However, after repeated cocaine exposure, it has been shown that 
differences in DAT function disappear, at least in the ventral striatum (Sabeti et al., 
2003).  Thus, the differential effects could be due to other consequences of 
neuroplasticity, like alterations in more specific dopaminergic and/or glutamatergic 
signaling in the PFC, as blunted dopaminergic and glutamatergic function are linked 
with impairments in PFC function (Brozoski et al., 1979; Seamans and Yang, 2004; 
Floresco and Magyar, 2006).   Studies from Arnsten’s and Goldman-Rakic’s groups 
(Zahrt et al., 1997; Vijayraghavan et al., 2007) suggest that optimal levels of DA D1 
receptor stimulation contribute to the most advantageous cognitive performance, with 
insufficient or excessive stimulation leading to impaired performance in mPFC-sensitive 
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tasks.  In essence, a normal neuromodulatory drive would lead to a balance of 
excitation and inhibition and result in normal PFC function, while an altered one would 
lead to dysfunctional behavioral performance.  
In summary, repeated and intermittent exposure to AMPH in adolescence leads 
to cognitive deficits later in life.  This same exposure method does not lead to deficits in 
adult-treated rats.  In contrast, similar deficits are seen in adult-treated, but not 
adolescent-treated, rats that were exposed to an escalating dose-binge treatment 
method.  These results are the first to report such findings for both intermittent and 
escalation-binge exposures.  Moreover, very few studies carefully examine both the 
locomotor profiles and cognitive behavior in the same animals.  These deficits appear to 
be closely associated with initial differences in cocaine-induced locomotor activity rather 
than related to overlapping locomotor changes induced by repeated drug treatment (i.e., 
sensitization).  Understanding the disruptions in plasticity within separate brain regions 
and targeting of circuit imbalances should play a major role in therapeutic advances in 
drug use and dependence.  With findings of differential vulnerabilities that are age- and 
pattern of drug exposure-dependent, we predict that these differences are the result of 
distinct mechanisms within the mesocorticolimbic networks, especially given that 
cortical and subcortical regions mature at different rates during adolescence (Tau and 
Peterson, 2010).   Further explorations between the functional interactions of multiple 
systems—namely, the hippocampus, mPFC, and ventral striatum—are warranted in 
order to better understand the role of development and subsequent neural mechanisms 
of chronic drug exposure.  
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CHAPTER 5: ADAPTATIONS IN MEDIAL PREFRONTAL CORTEX FUNCTION 
ASSOCIATED WITH AMPHETAMINE-INDUCED BEHAVIORAL SENSITIZATION4 
 
 
Abstract 
Neuroadaptations in the prefrontal cortex (PFC) are hypothesized to play an 
important role in the behavioral changes associated with repeated psychostimulant drug 
exposure.  However, studies that measure neuronal activity during drug-induced 
behavior are few in number, and they have not described how firing activity in the 
medial PFC (mPFC) is altered during the development and expression of 
psychostimulant sensitization.  To address this, we recorded single neuron activity in 
the mPFC of male rats (n=9) that were exposed repeatedly to saline or amphetamine 
(AMPH; 1.0 mg/kg, i.p.) for five days.  Daily recordings were obtained in an open-field 
environment for the five treatment sessions and after two challenge injections (saline or 
1.0 mg/kg AMPH) that followed a 3-day withdrawal (or drug-free) period.  We found that 
rats exposed to AMPH developed locomotor sensitization to the drug that emerged on 
the fifth treatment session and became statistically significant at AMPH challenge.  This 
was associated with no change in baseline (i.e., pre-injection) activity of mPFC neurons 
across the treatment or challenge sessions.  Following the first AMPH injection, mPFC 
neurons responded primarily with reductions in firing, with the overall pattern and 
magnitude of responses remaining largely similar following repeated treatment.  The 
exception was in the minority of cells that respond to AMPH with increases in firing rate. 
In this population, the magnitude of excitations peaked during the fifth AMPH exposure 
                                                 
4
 This chapter appeared in its entirety in the journal Neuroscience as Gulley JM, Stanis JJ 
(2010) Adaptations in medial prefrontal cortex function associated with amphetamine-induced 
behavioral sensitization. 166(2):615-24.  This article is reprinted with the permission of the 
publisher and is available from http://www.sciencedirect.com and using DOI: 
10.1016/j.neuroscience.2009.12.044 
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and was still relatively elevated at the AMPH challenge.  Furthermore, these units 
increased firing during a saline challenge that was given to assess associative 
conditioning.  These results suggest that AMPH-induced adaptations in mPFC function 
are not as apparent as AMPH-induced adaptations in behavior.  When mPFC 
adaptations do occur, they appear limited to the population of neurons that increase 
their firing in response to AMPH.  
 
Introduction 
When psychostimulant drugs are administered repeatedly, they have a significant 
potential to produce either a reduction (tolerance) or an increase (sensitization) in 
responsiveness after subsequent exposure to the same or lower doses.  In laboratory 
animals, the most frequently studied effect with drugs such as cocaine and 
amphetamine (AMPH) is sensitization.  In rats and mice, for example, repeated but 
intermittent exposure to these drugs results in augmentation of species-specific motor 
behaviors such as locomotion, head movement and sniffing, and stereotyped (i.e., 
repetitive) head, limb, and orofacial movements (Segal and Schuckit, 1983).  The extent 
and duration of this sensitization is influenced by drug dose, treatment regimen, and 
environmental context (Robinson and Becker, 1986; Badiani and Robinson, 2004). 
Sensitization has also been described in humans, especially in relation to AMPH-
induced psychosis (Robinson and Berridge, 1993) and AMPH-induced euphoria, drug 
“liking” and motor activation (Strakowski et al., 1996, 2001; Boileau et al., 2006). 
It is hypothesized that these enduring behavioral changes are the result of drug-
induced neuroadaptations, particularly within the brain's reward circuitry (Robinson and 
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Kolb, 2004; Jones and Bonci, 2005; Kauer and Malenka, 2007).  For example, 
increases in apical dendrite length, spine density, and the number of branched spines in 
the nucleus accumbens (NAc) and prefrontal cortex (PFC) have been demonstrated 
after both experimenter- (Robinson and Kolb, 1997, 1999; Singer et al., 2009) and self-
administered (Robinson et al., 2001; Crombag et al., 2005) cocaine or AMPH.  
Repeated AMPH exposure has also been shown to increase the number of synapses 
onto spines in the infralimbic and prelimbic regions of the medial PFC (mPFC; Morshedi 
et al., 2009).  These drug-induced changes have been shown to persist for long periods 
of time, as much as 3.5 years following AMPH administration in a study of the PFC in 
non-human primates (Selemon et al., 2007).  Repeated exposure to cocaine or AMPH 
also has been shown to produce long-lasting changes in neuronal excitability and 
synaptic efficacy in the ventral tegmental area (VTA), NAc, and PFC (Onn and Grace, 
2000; Thomas et al., 2001; Dong et al., 2005; Nogueira et al., 2006; Peterson et al., 
2006; Kourrich et al., 2007; Chen et al., 2008; Ford et al., 2009). 
The relationship between these drug-induced adaptations and the expression of 
behavioral sensitization is not clear, however, because the aforementioned studies 
utilized in vitro methods that required correlation of the observed anatomical or 
functional changes with the behavioral responses that animals expressed well before 
the neuroadaptations were assessed.  For example, in the studies of neuronal function, 
one or several days elapsed between the last drug injection and the measurement of 
NAc or PFC activity.  One method of more directly assessing this relationship is to 
perform in vivo electrophysiology recordings from behaving animals as they undergo 
repeated drug exposure and subsequent challenge injections.  However, in the 
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comparatively few studies where this was done in rats with a history of cocaine 
(Stalnaker et al., 2006; Sun and Rebec, 2006) or AMPH (Homayoun and Moghaddam, 
2006) exposure, there was no description of neuronal responses as they related to 
drug-induced behavior and the expression of behavioral sensitization.  One noteworthy 
exception to this is a recent report (Ball et al., 2006) of adaptations in the function of 
neurons in the dorsal striatum following repeated exposure to (±)3, 4-
methylenedioxymethamphetamine (MDMA, or ecstasy).  In this study, units recorded 
from rats that expressed locomotor sensitization to MDMA increased their firing rate to a 
greater extent following MDMA challenge compared to the first exposure to MDMA. 
In the current study, we investigated the relationship between AMPH-induced 
behavioral sensitization and both baseline and AMPH-induced changes in mPFC 
activity using in vivo electrophysiological recording methods.  We focused on the mPFC 
because a number of previous studies have highlighted its important role for not only 
the acute locomotor response to AMPH (Dunnett et al. 1984; Bast et al. 2002; Hall et 
al., 2009), but also the development and expression of locomotor sensitization following 
repeated AMPH exposure (Wolf et al., 1995; Cador et al., 1999; Bjijou et al. 2002). 
Recordings were obtained as rats behaved in an open-field arena before and after daily 
injections of saline or 1.0 mg/kg AMPH, with subsequent analyses performed on data 
from four recording sessions: treatment day 1, treatment day 5, and two separate 
challenge injection sessions.  During these challenge sessions, which occurred on 
consecutive days and were preceded by three days during which rats remained in their 
home cage, rats were given either saline or AMPH to test for evidence of conditioning 
and locomotor sensitization, respectively. 
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Methods 
Subjects.  Male Sprague-Dawley rats (n = 9), bred in our animal facility from 
stock rats obtained from Harlan (Indianapolis, IN), were housed individually starting at 
~2 months of age and were 3-5 months old (375-500g) at the beginning of experiments.  
They were maintained on a 12:12 h light:dark cycle (lights on at 0800) with food and 
water available ad libitum.  Rats were handled five times for 15 min intervals prior to 
being used in experiments, which were conducted between 0900 and 1800 h.  All 
experimental procedures were approved by the IACUC at the University of Illinois, 
Urbana-Champaign and were consistent with the Principles of Laboratory Animal Care 
(NIH Publication no. 85-23).   
Electrode construction and surgical procedures.  Electrode bundles were 
constructed of 16 or 32 formvar-coated nichrome microwires (25 m diameter; A-M 
systems, Sequim, WA) that were cut and assembled into single cylindrical bundles.  The 
bundles were placed in customized stainless steel tubing (22G; Small Parts, Miami 
Lakes, FL) before being attached with conductive epoxy to 10-pin connectors 
(Omnetics; Minneapolis, MN).  Ground wires, which were constructed from Teflon-
coated stainless steel wire (140 m diameter; A-M systems) with insulation removed at 
the ends, were attached to a stainless steel machine screw (#0-80; Small Parts) and 
one channel of the connector.  Impedances on recording electrodes were reduced to 
0.3-1.0 MΩ by passing current through sterile saline solution (“saline bubbling”). 
Electrode bundles were implanted unilaterally into the mPFC of rats that were 
anesthetized with ketamine and xylazine (100 and 10 mg/kg, i.m., respectively, followed 
by 25 mg/kg ketamine, i.p., boosters as needed).  A moisturizing lubricant (Moisture 
 83 
Eyes PM; Bausch & Lomb, Rochester, NY) was applied to prevent corneal drying.  
Holes were drilled over the right mPFC (3.0 anterior-posterior and 1.3 medial-lateral to 
bregma; Paxinos and Watson, 1998) and at several other anterior and posterior skull 
positions for the insertion of stainless steel screws to anchor dental acrylic and the 
ground wires.  In the hole overlying the mPFC, the dura was reflected with a 27G 
needle tip and electrode bundles were lowered 4.2 mm dorsal-ventral at a 9.5 angle 
towards the midline.  When necessary, the craniotomy was sealed with silastic material 
(Kwik-Sil; WPI, Inc., Sarasota, FL) before the application of dental acrylic.  An analgesic 
dose of carprofen (5.0 mg/kg, s.c.) was administered every 6-12 hours for the first day 
after surgery.   
Electrophysiological techniques.  Each microwire was connected to one channel 
of a 32-channel unity gain field effect transistor preamplifier.  Signals from this 
headstage amplifier were transmitted via lightweight cabling through a multi-channel 
commutator (Plexon Inc.; Dallas, TX) that allowed the rat to move freely in the testing 
environment.  For extracellular unit data, signals were amplified, band-pass filtered (250 
Hz to 8 kHz) and digitized (40 kHz sampling rate).  Signal acquisition and real-time 
spike sorting was accomplished via digital signal processors located within a 
Multichannel Acquisition Processor (MAP; Plexon, Inc.).  For open-field chamber 
recordings, videos were captured and time-stamped (CinePlex; Plexon, Inc.) for later 
synchronization of behavior with neural activity (e.g., peri-event time histograms, or 
PETHs). 
Spike activity was separated from background on each of the 16 or 32 channels 
using a combination of manual and semi-automated methods (Sort Client and Offline 
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Sorter; Plexon, Inc.).  Initially, an absolute refractory period of at least 1.1 ms and a 
waveform amplitude threshold of at least 2.5 standard deviations (SDs) higher than the 
noise amplitude were used to isolate single units from background; obvious noise 
artifacts were also removed from the data set.   In addition to waveform template 
matching, clustering algorithms and principle component analysis (PCA) were used to 
optimize these discriminations (Fig. 5.3A).  Spike activity was identified as originating 
from putative interneurons or pyramidal cells based on well-established 
electrophysiological criteria (Kim and Conners, 1993; Mainen and Sejnowski, 1996; 
Jung et al., 1998; Barthó et al., 2004) that included action potential waveform shape and 
spike duration, mean discharge rates, inter-spike interval histograms, and 
autocorrelograms.  Specifically, single-unit activity was considered to be from putative 
interneurons if it had a high firing rate that followed a regular pattern, whereas pyramidal 
neurons were identified by burst firing patterns with peaks at 3-10 ms in their 
autocorrelograms (if the maximum peak is  50% of the maximum bin value of the first 
50 ms; Fig. 5.3B) or regular-spiking with a slow-rising slope in their autocorrelogram 
(mode of interspike-interval histogram > 35 ms).  Because well-separated putative 
interneurons made up a small sample of recorded cells (~5%), only data from putative 
pyramidal cells were used for further analyses.     
Behavioral testing.  Tests of locomotor activity were performed in an open-field 
arena, which consisted of a vinyl floor (41 cm x 41 cm) and 41 cm high Plexiglas walls.  
The arena was enclosed in a wooden black cubicle with a black curtain across the front.  
It was dimly illuminated with a Fiber-Lite illuminator (Dolan-Jenner, Lawrence, MA) that 
was mounted through holes in the ceiling of the surrounding cubicle.  Also mounted to 
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the cubicle ceiling was a small, high-resolution video camera.  An audio speaker was 
located on the side of the cubicle near the top, and on the opposite side a small LED 
cue light was centered at the bottom of the arena.  
Seven to ten days following surgery, rats were taken from the colony room to the 
testing room, the headstage was attached to the connectors implanted to their skull, and 
they were allowed to acclimate in a towel-lined holding pot.  On this and subsequent 
test days, rats underwent two daily recording sessions.  In a morning session, which 
was used to assess the stability of recorded units, rats rested in the holding pot and 
recordings lasted for ~15 min.  An afternoon session was used for testing and lasted for 
~1 hr 45 min.  It consisted of recording during a 15 min period of rest in the holding pot 
just outside the open-field arena, a 30 min habituation period inside the open-field 
arena, a 45 min period in the open-field arena after they had been removed and injected 
(i.p.) with either 1.0 ml/kg saline or 1.0 mg/kg AMPH, and a 15 min period in the holding 
pot.  Rats were then returned to the colony room. 
On Day 1 (saline pre-test), all rats were injected with saline during the afternoon 
session.  On subsequent test days, five rats were given AMPH (AMPH group) and two 
rats were given saline (saline group) using a protocol we have used previously to 
demonstrate AMPH-induced locomotor sensitization and conditioned behavior (Hall et 
al., 2008).  On days 2-6 (tests 1-5), rats received either saline alone or AMPH and a 
compound stimulus (28 V, white LED and a 1 kHz, 55dB tone) that was presented in a 5 
sec on/5 sec off pattern for the duration (45 min) of the post-injection recording in the 
open-field arena.  Following a three-day withdrawal period where they remained in the 
colony room, rats began the first of two daily afternoon sessions with a saline or AMPH 
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challenge.  For the first challenge session, all rats received saline but the AMPH group 
was presented with the compound stimulus.  For the second challenge session, rats in 
the saline group were given another saline injection whereas those in the AMPH group 
were given an AMPH challenge (1.0 mg/kg, i.p.).  For both groups, the compound 
stimulus was presented for the duration of the post-injection period.     
Histology.  Following the last test session, rats were deeply anesthetized with 
chloral hydrate and marking lesions were produced by passing current (50 A, cathodal; 
5 s) through electrode channels where presumed mPFC neurons were recorded.  Rats 
were then perfused transcardially with 0.9% saline and a solution of 5% potassium 
ferrocyanide in formalin, which reacted with metal deposits at the lesion site to produce 
a blue-green stain.  Brains were removed and stored in formalin until they were frozen 
and sectioned (60 μm thickness) on a sliding microtome.  A light microscope was used 
to analyze cresyl violet stained sections for electrode tracks and tip locations.  Only data 
obtained from those electrodes determined to be in the vicinity of neurons in layer V of 
the prelimbic or infralimbic regions of the mPFC (as defined by Paxinos and Watson, 
1998) were used for subsequent analysis.  Locations of these recording locations are 
shown schematically in Fig. 5.1.      
 Drugs.  The d-AMPH sulfate used in this study was obtained from Sigma-Aldrich 
(St. Louis, MO).  It was dissolved in sterile saline (0.9% NaCl), with the dose calculated 
based on the weight of the salt.  All injections were given at a volume of 1 ml/kg. 
  Data analysis.  Statistical analyses were conducted using SigmaStat 3.5 (Systat 
Software, Inc.; San Jose, CA) and p values less than 0.05 were considered significant.  
Locomotor activity before and after injections (saline or AMPH) was quantified by 
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measurement of quadrant crossings in the open-field and summarized into mean values 
for the 45-min post-injection time period.  These data were analyzed using two-way, 
mixed factor ANOVA (with session as the repeated factor) followed by Holm-Sidak post-
hoc analysis.   
Electrophysiological data were imported into NeuroExplorer (NEX Technologies, 
Littleton, MA) for summary and analysis using similar methods to those we (Gulley et 
al., 2002, 2004) and others (Homayoun and Moghaddam, 2006) have described 
previously.  Units recorded on different treatment days were treated as independent 
units, even though the anchoring of the electrode connectors would suggest that the 
same or similar populations of cells were sampled across days.  Analysis of baseline 
firing was done using the first and second 15-min time intervals of the 30-min pre-
injection recording period.  These were chosen because the first 15 min represents a 
period when rats were actively engaging in exploratory behavior.  During the second 15 
min, rats were relatively inactive, usually only exhibiting brief periods (< 5 s) of sniffing 
or head movements.  Firing rate (spikes/s) was first analyzed using three-way ANOVA 
(group × session × baseline period) followed by two-way, mixed factor ANOVA (with 
baseline period as the repeated factor) for each of the treatment and challenge 
sessions.  This was followed by Holm-Sidak post-hoc analysis where appropriate. 
Changes in firing rate after saline or AMPH administration were analyzed by first 
determining if there was a consistent alteration in firing during the post-injection period 
compared to the baseline period preceding injection.  Units were characterized as 
increased or decreased if the mean firing rate following injection was below or above, 
respectively, the 99% confidence interval of the baseline firing rate, (1) for at least four 
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consecutive 5-min bins, or (2) for five of the nine 5-min bins that were recorded post-
injection.  Those units that did not meet this criterion were classified as not changed. 
Chi-square (χ2) tests were used to compare the distribution of these response types 
between treatment groups and within treatment groups across sessions.  Bonferroni 
correction was used to determine the threshold for statistical significance as a control 
for Type 1 error introduced by the performance of multiple chi-square tests.  Thus, the 
effective α level for these tests was p < 0.005.  Mean firing rate for units in these 
categories was then analyzed using a three-way ANOVA (group × session × response 
type) followed by two-way ANOVA (group × response type) for each of the treatment 
and challenge sessions.  Post-hoc comparisons were done with Holm-Sidak tests. 
Burst firing was assessed using the interval specification algorithm in 
NeuroExplorer using the following parameters: maximum onset interspike (ISI) interval 
of 80 ms, minimum offset ISI interval of 160 ms, maximum between-burst interval of 6 
msec, minimum burst duration of 10 msec, and a minimum of 3 spikes in a burst). 
Similar parameters have been used previously in an analysis of cocaine-induced 
changes in mPFC burst firing (Sun and Rebec, 2006).  Analysis of burst rate 
(bursts/min) during the active and inactive baseline periods was done as described 
above for firing rate.  For analysis of changes in burst activity following saline or AMPH 
injection, burst rate and % of spikes in bursts during the 5-min period just before 
injection was compared to that observed following saline or AMPH using a three-way 
ANOVA (group × session × time period).  To address within- and between-group 
variability in burst activity during baseline and allow for a more direct comparison 
between groups and across recording sessions (Homayoun and Moghaddam, 2006), 
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the post-injection burst activity for each unit was also normalized to its own activity prior 
to injection and expressed as a percentage of baseline.  These data were analyzed with 
two-factor ANOVA (group × session) followed by Holm-Sidak post-hoc analysis. 
In order to analyze responses of mPFC units to the light/tone cue presented 
following injections, PETHs with a bin size of 25 ms were constructed around 270 
pairings with the light and tone cues.  Evidence for robust changes related to these 
events was evaluated by calculating the firing rates for 150 ms after stimulus onset or 
offset and determining if these were at least 2 SDs above or below the mean firing rate 
during the previous 500 ms (Gulley et al., 2002). 
 
Results 
Locomotor behavior 
Analysis of quadrant crossing for rats in the saline and AMPH treatment groups 
revealed significant main effects of group [F(1,40) = 11.8, p = 0.01] and session [F(4,40) 
= 4.75, p < 0.01], along with a significant group × session interaction [F(4,40) = 5.07, p < 
0.01].  As shown in Fig. 5.2, repeated treatment with saline did not change subsequent 
behavioral responses to saline on test days 1 and 5 or on either of the challenge 
sessions.  AMPH (1.0 mg/kg, i.p.), however, produced an increase in locomotor activity 
during treatment 1, and subsequent repeated exposure induced sensitized locomotor 
behavior that began to appear on the fifth treatment day and became statistically 
significant on the AMPH challenge (i.e., challenge 2).  To determine whether 
conditioning occurred in response to repeated AMPH exposure, a saline challenge was 
performed on the first day after withdrawal (i.e., challenge 1).  The presence of 
conditioning was defined as an increase in locomotor activity on challenge 1 compared 
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to the first injection with saline and to the activity in rats repeatedly exposed to saline. 
Although the number of quadrant crossings following saline challenge was greater (> 2-
fold increase) than those observed after the first saline injection, this difference was not 
statistically significant (p > 0.67). 
 
Basal mPFC activity 
A total of 349 single units were recorded from the prelimbic and infralimbic 
regions of the mPFC during the first and fifth treatment days, as well as during 
challenge 1 and 2.  During the 30 min they were in the open-field arena prior to 
injection, rats typically engaged in exploratory behaviors such as locomotion, rearing, 
and sniffing for the first 15 min (“active” period) and then rested with only occasional 
movement (e.g., sniffing, head movement, or brief body movements) for the last 15 min 
(“inactive” period).  Table 5.1 shows the mean firing and burst rate for these periods of 
high and low spontaneous activity.  Overall, there was little evidence of movement-
related changes in activity the two treatment groups and there were no consistent 
changes in baseline activity across recording sessions.  The one exception was the 
small, but significant increase in firing and burst rate that was observed in the inactive 
period on treatment 5 in rats from the saline-treated group.  This statistically significant 
difference was revealed via significant main effects of session [firing rate: F(3,696) = 
5.88, p < 0.001; burst rate: F(3,649) = 3.84, p < 0.05] and group [firing rate: F(1,696) = 
5.66, p < 0.05; burst rate: F(3,696) = 5.06, p < 0.05] in the overall ANOVA and a 
significant group × baseline interaction [firing rate: F(1,167) = 15.6, p < 0.001; burst rate: 
F(1,161) = 8.68, p < 0.01] in follow-up analysis.  Similarly, there was evidence of 
between-group differences in baseline mPFC activity on challenge 2 [main effect of 
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group; firing rate: F(1,160) = 4.07, p < 0.05; burst rate: F(1,149) = 7.59, p < 0.01], with 
firing and burst rate reduced in AMPH-treated rats.  This result was only significant 
when data were collapsed across the active and inactive baselines, however, as the 
group × baseline interactions on challenge 2 were not significant (p values > 0.59). 
 
mPFC activity after saline or AMPH treatment 
Following the first injection with 1 mg/kg AMPH (i.e., treatment 1), the majority of 
mPFC neurons significantly changed firing rate compared to their own baseline and to 
the firing of units recorded from rats given saline (Fig. 5.4A; χ2 = 16.3, p < 0.001). 
These changes were mostly reductions in firing, with smaller populations of cells either 
increased or not consistently changed.  The responses in saline- compared to AMPH-
treated rats were also significantly different following the fifth treatment (χ2 = 12.2, p = 
0.002).  During treatment 5 compared to treatment 1 in rats given AMPH, there tended 
to be fewer cells that did not consistently change and more cells that increased their 
firing post-injection (Fig. 5.4A).  However, this change in the proportion of response 
types was not statistically significant.  In response to the first challenge, where both 
groups received saline injections and the AMPH group was exposed to a light/tone cue 
previously associated with AMPH injection, there was not a significant difference in the 
proportion of responses between groups.  There was, however, a significant change in 
the proportion of responses in the AMPH groups in comparison to those observed after 
the first treatment (χ2 = 18.4, p < 0.001).  Specifically, following injection there were 
significantly more units that did not consistently change or increased their firing and 
significantly fewer cells that decreased their firing.  During challenge 2, when both 
groups were presented the light/tone cue and both received the same injection type 
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they had received on treatments 1 and 5, there was a significant group difference in the 
proportion of response types: 67% of the cells recorded from rats in the AMPH group 
exhibited decreases in firing following injection, whereas 59% of the cells recorded from 
rats in the saline group exhibited no consistent change (χ2 = 22.0, p < 0.001).  This 
response pattern in the AMPH treatment group was not significantly different from that 
seen at treatment 1, however. 
As shown in Fig. 5.4B, there were significant group differences in the magnitude 
of firing rate changes following injections on the treatment and challenge days.  A three-
way ANOVA of these data revealed significant main effects of session [F(3,339) = 2.68, 
p < 0.05] and response type [F(2,339) = 66.4, p < 0.001], along with significant two-way 
interactions [group × session: F(3,339) = 2.89, p < 0.05; group × response type: 
F(2,339) = 9.25, p < 0.01; session × response type: F(6,339) = 3.60, p < 0.01].  Follow-
up, two-way ANOVA analyses on data from individual sessions revealed that on 
treatments 1 and 5, the decreases or increases in baseline that were seen in units from 
AMPH-treated rats were significantly different from the post-injection firing observed in 
units classified as not changed (Fig. 5.4B).  Furthermore, the magnitude of AMPH-
induced excitation was greater on treatment 5 compared to treatment 1.  For units 
classified as increased following AMPH injection, these normalized firing rates were 
also significantly different from those observed in saline-treated rats.  When all rats 
were challenged with saline following the three-day withdrawal period (i.e., Ch 1), only 
the units recorded from rats in the AMPH treatment group and classified as increased 
following injection were significantly different from those classified as not changed. 
Furthermore, the magnitude of this increase was significantly higher in AMPH-treated 
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compared to saline-treated rats. Following AMPH challenge (i.e., Ch 2), the magnitude 
of AMPH-induced decreases and increases in firing was similar to that seen on 
treatment 1, though only those classified as increased were significantly different from 
those classified as not changed. In the saline-group, the magnitude of the firing rate 
increase on challenge 2 was significantly greater than that observed during treatment 1. 
During this challenge session, these rats were given saline but they were also exposed 
to a light/tone cue for the first time. 
Analysis of burst firing in the mPFC neurons recorded here revealed that AMPH 
tended to decrease both burst firing rate (Fig. 5.5A) and the percentage of spikes in 
bursts (Fig. 5.5C) compared to baseline, but this effect was only evident on the first 
treatment day and the AMPH challenge session.  An overall three-way ANOVA of these 
data revealed significant main effects of session for both measures [burst rate: F(3,649) 
= 6.29, p < 0.001; percentage of spikes in bursts: F(3,649) = 2.92, p < 0.05].  In 
addition, there was a significant main effect of group for burst rate [F(1,649) = 8.86, p < 
0.01] and a significant session × group interaction for percentage of spikes in bursts 
[F(3,649) = 3.37, p < 0.05].  To account for both within- and between-group variability in 
bursting, data were normalized for each cell to its pre-injection baseline.  A two-way 
ANOVA of the normalized burst rate revealed a significant main effect of session 
[F(1,273) = 3.26, p < 0.05] and a significant group × session interaction [F(3,273) = 
5.16, p < 0.01].  As shown in Fig. 5.5B, burst rate was significantly increased in the 
AMPH-treated group at challenge 1 when compared to the saline group and to the burst 
rate in cells recorded form the AMPH group at the first treatment.  On challenge 2, the 
treatment groups were also significantly different from each other, with the saline group 
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having a higher burst rate.  As shown in Fig. 5.5D, the percentage of spikes in bursts 
was significantly reduced in the AMPH- compared to the saline-treated group during 
treatment 5 and challenge 2.  At challenge 1, there was a significant increase in the 
percentage of spikes in bursts in units recorded from the AMPH-treated group 
compared to those treated with saline and to units recorded from the AMPH group after 
the first injection with AMPH. 
In order to assess the potential for modulations in mPFC firing rate that were 
specific to the cues presented to rats in the AMPH group following injections with AMPH 
on treatments 1 and 5 and challenge 2, or following saline on challenge 1, PETHs were 
constructed with cue onset or offset as the reference event.  We found no evidence of 
statistically significant, cue-related modulations in firing during any of the treatment or 
challenge sessions (data not shown).  When this same analysis was done for saline-
treated rats on challenge 2, we also did not find any units that exhibited significant cue-
related changes in firing (data not shown). 
 
Discussion 
The goal of this study was to investigate AMPH-induced adaptations in the 
function of mPFC neurons that, based on results from previous anatomical and in vitro 
electrophysiological studies, are expected to emerge along with the behavioral 
adaptations that typically result from repeated AMPH exposure (i.e., behavioral 
sensitization).  This was accomplished by utilizing chronically implanted microwire 
electrodes to record the activity of mPFC neurons during a baseline period and after 
injections of either saline or AMPH in rats there were allowed to behave in an open-field 
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arena.  We found that during baseline recording (i.e., pre-injection), neurons in the 
mPFC generally did not modulate their spiking activity during periods of spontaneous 
movement relative to periods of inactivity.  Furthermore, in rats given AMPH repeatedly, 
there was no consistent, statistically significant change in baseline firing or burst rate 
across treatments or AMPH challenges.  Thus, repeated AMPH exposure did not 
produce a significant “hypofrontal” state as might be predicted from studies in humans 
with a long history of cocaine abuse (Goldstein and Volkow, 2002) and those in rodents 
showing that PFC-mediated glutamate release in the NAc is reduced in cocaine-
sensitized rats (Pierce et al., 1996; Hotsenpiller et al., 2001; McFarland et al., 2003). 
Reduced baseline spiking activity in the mPFC has also been reported in rats with a 
relatively long history of cocaine self-administration experience (Sun and Rebec, 2006). 
Consistent with the present results, however, is the finding that repeated exposure to 
0.5 or 2.0 mg/kg AMPH had no significant effect on baseline mPFC activity recorded 
from behaving rats (Homayoun and Moghaddam, 2006).  Thus, the development of 
drug-induced hypofrontality in the mPFC may be influenced by the duration of drug 
exposure, whether the drug is self-administered or given non-contingently, and also by 
the type of drug. 
Following its first injection, 1.0 mg/kg AMPH had primarily inhibitory effects on 
both firing rate and bursting in the mPFC.  Mostly inhibitory responses have been 
described previously in anesthetized rats given a single injection of 1 or 2 mg/kg AMPH 
(Mora et al., 1976) and in brain slices where local application of AMPH leads to a 
depression of excitatory field potentials in layer V neurons that are evoked by layer II/III 
stimulation (Mair and Kauer, 2007).  In recordings from awake, behaving rats, inhibitory 
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responses also predominated following a single dose of 2 mg/kg AMPH, whereas 
excitatory responses are more common following acute exposure to 0.5 mg/kg AMPH 
(Homayoun and Moghaddam, 2006).  When taken with the latter study, the present 
results suggest the primary response in the mPFC to lower AMPH doses is opposite to 
that seen with higher doses.  This may be relevant for the therapeutic effects of AMPH 
in disorders such as attention deficit hyperactivity (ADHD) where the effective dose 
range is typically 0.2-0.5 mg/kg (Solanto, 2000). 
By the fifth injection of AMPH, when locomotor sensitization began to emerge, 
the pattern of mPFC unit responses to the drug was generally similar to that observed 
following the first injection – AMPH-induced inhibitions in firing rate predominated. 
However, the magnitude of excitatory responses, which represented 24% of the 
recorded neurons, was significantly increased from ~ 267% of baseline to ~474% of 
baseline on treatment 1 and 5, respectively.  Following AMPH challenge, these drug-
induced excitations were also of a greater magnitude (~350% of baseline) compared to 
treatment 1.  Importantly, this occurred when locomotor sensitization to AMPH was 
clearly evident.  These changes in the magnitude of excitation were also associated 
with decreases in the rate of bursting during AMPH challenge and decreases in the 
number of spikes in bursts during treatment 5 and the AMPH challenge.  It may be the 
case, therefore, that in behaving animals, the population of neurons excited by AMPH is 
more vulnerable to the plasticity induced by repeated AMPH exposure compared to the 
population inhibited by the drug.  This hypothesis requires further study, particularly 
using techniques that allow for the simultaneous analysis of behavior and neuronal 
function. 
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Relative to units recorded from saline-treated rats, we observed increased burst 
activity associated with increases in locomotion following saline challenge in the AMPH-
treated group.  This may be related to an increased ability to process drug-paired 
information (Childress et al., 1999; Rebec and Sun, 2005; Sun and Rebec, 2006), as 
the PFC is well known to be involved in learning-related plasticity in rats (Mulder et al., 
2003; Schoenbaum et al., 2003; Bouret and Sara, 2004).  A specific role for associative 
conditioning in AMPH-induced adaptations in the mPFC was also highlighted in a recent 
study showing that drug-induced changes in dendritic morphology in the mPFC were 
only observed in those rats given systemic injections of AMPH and not those given local 
AMPH infusions into the ventral tegmental area (Singer et al., 2009).  Both of these 
routes of AMPH exposure induce locomotor and neurochemical sensitization in the 
NAc, but only systemic exposure produces conditioned responding (Stewart and 
Vezina, 1991; Vezina, 1996).  An alternative hypothesis is that the increased firing rate 
and burst activity we observed could have resulted in response to the novel situation 
presented by the first pairing of cues (tone and light) with saline rather than AMPH. 
While this explanation is plausible, it is noteworthy that saline-treated rats did not show 
a statistically significant increase in burst activity when they experienced this novel 
situation for the first time (i.e., challenge 2 where saline injection was paired to the tone 
and light cues).  Thus, the changes in mPFC activity observed following saline 
challenge are more likely related to the conditioned behavior observed and may 
represent a change in responsiveness to the overall environmental context.  The lack of 
temporal specificity we observed in our PETH analysis of cue-specific modulations in 
mPFC activity may also be a reflection of this more global response to the drug-
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associated context. 
The PFC is part of a widely distributed neuronal network that has extensive 
reciprocal connections with both cortical and subcortical regions (Kolb, 1984).  Thus, it 
is positioned to play a critical role in organizing behavior through functional regulation of 
numerous subcortical structures.  The pyramidal cells in the mPFC, which are more 
than likely the source of the unit responses we recorded, are known to project densely 
to limbic structures such as the NAc, hippocampus, and amygdala (Sesack et al., 1989; 
Vertes, 2002; Heidbreder and Groenewegen, 2003).  Moreover, the prelimbic and 
infralimbic areas receive the densest innervation of VTA dopamine efferents relative to 
dorsal regions of the mPFC (Lindvall et al., 1978).  Thus, it was somewhat unexpected 
to find that neuroadaptations in the response to AMPH in the mPFC were not as 
apparent as those observed for AMPH-induced locomotor behavior.  It is likely that 
AMPH-induced adaptations in the mPFC are dependent on the exposure dose, method 
of drug administration, and duration of withdrawal before challenge.  Unfortunately, no 
other published studies have systematically described mPFC plasticity concurrently with 
AMPH-induced adaptations in the behavioral response. It has been reported, however, 
that higher doses of repeated AMPH or cocaine treatment, along with longer withdrawal 
time periods, altered the electrophysiological properties of mPFC neurons in vitro 
(Peterson et al, 2006), in anesthetized rats in vivo (Onn and Grace, 2000; Peterson et 
al., 2000; Trantham et al., 2002), and in awake rats (Homayoun and Moghaddam, 2006; 
Sun and Rebec, 2006). In the only other published report of mPFC recording in 
behaving rats, 2 mg/kg AMPH given once per day for 5 days was reported to shift 
mPFC responses to AMPH such that a greater number of AMPH-induced inhibitions 
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were observed when a challenge injection of AMPH was given 10 days after the fifth 
drug treatment.  A second AMPH challenge given 14 days after the first revealed that 
this response to AMPH persisted (Homayoun and Moghaddam, 2006).  In this study, 
however, locomotor activity data were not presented, so it is unclear if the observed 
plasticity in the mPFC was associated with adaptations in the behavioral response to 
AMPH at both of the challenges.  Because the recordings in this study were obtained 
while rats were in their home cages, it is possible that the inconsistencies with our 
results are related to the absence of AMPH-induced locomotor sensitization.  The 
importance of environmental context for the development and expression of 
psychostimulant sensitization has been well documented (Badiani and Robinson, 2004), 
and single-unit recordings from the mPFC have highlighted its sensitivity to context-
discrimination and sensorimotor information (Gemmell et al., 2002; Baeg et al., 2003; 
Euston and McNaughton, 2006; Cowen and McNaughton, 2007).  Thus, it is 
conceivable that different neuroadaptations can be induced by repeated AMPH 
exposure and that they are influenced by the behavioral state of the animal. 
In summary, we found that repeated exposure to AMPH, using a treatment 
schedule that resulted in locomotor sensitization to AMPH, leads to selective and 
relatively modest changes in mPFC function.  In particular, AMPH-induced increases in 
activity were enhanced following five days of repeated treatment and persisted, but to a 
lesser extent, during an AMPH challenge given following a 3-day withdrawal period. 
AMPH-induced decreases in mPFC activity, which were the more frequently 
encountered type of response, were not significantly changed over the course of 
treatment or following challenge injections.  When taken with other studies in behaving 
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rats where repeated cocaine (Sun and Rebec, 2006) or AMPH (Homayoun and 
Moghaddam, 2006) were shown to produce more robust and longer lasting changes in 
baseline mPFC function and in the response of mPFC neurons to drug challenges, our 
findings suggest that AMPH-induced plasticity in the mPFC is highly dependent on 
treatment factors such as dose, duration of withdrawal, and the treatment environment. 
Furthermore, they highlight the importance of measuring the neuronal and behavioral 
consequences of repeated drug exposure concurrently.  By doing so, it is possible to 
more directly correlate neural adaptations with the expression (or absence) of 
behavioral adaptations.  This is particularly important in regards to the mPFC because it 
has been demonstrated that sensitizing regimens of AMPH treatment have long lasting 
effects on drug-induced locomotor behavior but do not significantly alter mPFC-sensitive 
behavioral tasks such as delay-discounting (Stanis et al., 2008b), delayed non-matching 
to position (Featherstone et al., 2008), or delayed spatial alternation (Stefani and 
Moghaddam, 2002). 
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CHAPTER 6: GENERAL DISCUSSION 
 
Impulsivity and cognitive dysfunction are typically reported and possibly 
overlapping traits for a number of psychiatric disorders, including addiction (Dolan et al., 
2008; Ersche et al., 2012).  While we hypothesize that drug-induced changes in brain 
function are a major contributing factor to the behaviors that characterize addiction, it is 
not necessarily clear whether co-morbid personality traits like impulsivity and cognitive 
dysfunction predate the onset of drug use or occur as a consequence of chronic use.  It 
is known, however, that the progression from initial use to dependence involves 
synaptic plasticity in a number of brain pathways, with glutamate and dopamine 
systems being crucial for the ensuing plasticity (Seamans and Yang, 2004; Wolf et al., 
2004; Kalivas et al., 2008).  Increasing evidence points to the mPFC as a key region of 
regulating the manifestation of adaptations in response to chronic drug exposure (Li et 
al., 1999; Tzschentke and Schmidt, 1999; Bjijou et al., 2002; Morshedi et al., 2009; 
Fanous et al., 2011).  The purpose of this thesis was to examine the long-lasting effects 
of repeated AMPH exposure on cortical function and cognitive behavior.    
The experiments presented here first evolved from an initial study looking at the 
relationship between the locomotor response (i.e., the ability to induce sensitization) 
and mPFC firing activity in response to repeated AMPH treatment.  This study was 
based on the current theories that suggest neuroadaptations in the PFC are responsible 
for driving behavioral changes associated with chronic psychostimulant exposure 
(Goldstein and Volkow, 2002; Koob and Volkow, 2010; Kalivas and Volkow, 2011).  We 
implanted electrodes into the mPFC and recorded neuronal activity while rats were 
actively behaving in an open-field chamber before and after injections of AMPH (1.0 
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mg/kg).  We found that repeated AMPH led to very selective and modest changes in 
mPFC function when behavioral sensitization was present.  More specifically, an acute 
injection had primarily inhibitory effects on both firing rate activity and bursting patterns.  
These findings agree with recordings from anesthetized rats and in vitro studies (Mora 
et al., 1976; Mair and Kauer, 2007).  After five injections, when locomotor sensitization 
emerged, the magnitude of excitatory responses increased.  These changes were less 
persistent following AMPH challenge, which occurred after a three-day washout period 
(to ensure that the effects were due to long-lasting alterations rather than metabolic side 
effects).  The magnitude of excitation was also coupled with reduced rate and number 
of spikes within bursting.  Interestingly, during a cue challenge (i.e., saline injected in 
the presence of drug-associated cues), the AMPH-treated rats showed an increase in 
bursting activity.  Taken together, our data suggest that particular populations of 
neurons are more vulnerable to AMPH-induced plasticity.  This vulnerability can be 
interpreted in light of recent findings that suggest transient changes in specific PFC 
projection neurons (Hedou et al., 2002; Fanous et al., 2011).  In addition, several 
studies show that sensitizing regimens of AMPH does not necessarily lead to long-
lasting changes in behavioral tasks that are sensitive to changes in PFC function 
(Stefani and Moghaddam, 2002; Featherstone et al., 2008).  Focusing on plasticity 
within specific pathways will be key in future studies. 
We then wanted to examine the relationship between behavioral sensitization 
and impulsive choice behavior in the same animals after chronic drug treatment.  Rats 
were first repeatedly treated with AMPH and then trained in a delay-discounting task, 
which is sensitive to the rats’ inability to tolerate longer delays for a more advantageous 
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food reward.  We found that chronic exposure to AMPH did not cause rats to become 
more impulsive (saline- and AMPH-treated rats were equally impulsive), but we 
observed long-lasting changes in AMPH-induced locomotor activity.  These results were 
somewhat surprising because they suggested that the neuroadaptations, which are 
known to be associated with intermittent exposure and behavioral sensitization 
(Robinson and Berridge, 2000), did not cause enduring deficits in the aspects of 
cognition that the delay-discounting task requires.  While a number of studies suggest 
that impulsivity is modulated by DA (van Gaalen et al., 2006; Dalley et al., 2011; 
Economidou et al., 2012), the exact mechanisms are not yet clear and could involve 
both cortical and subcortical changes.  Furthermore, there are a number of behavioral 
tasks that measure aspects of impulsive behavior, so it is entirely possible that DA 
modulation produces more specific effects in other impulsive choice tasks, as reported 
in the literature (Peterson et al., 2003; Eagle et al, 2007; Navarra et al., 2008).  It is 
notable, however, that studies using similar AMPH treatment schedules as the one used 
here have reported impairments in both subsequent structural plasticity and memory 
tasks (Bisagno et al., 2003; Kolb et al., 2003; Briand et al., 2005; Castner et al., 2005; 
Belcher et al., 2006; Fletcher et al., 2007).  Our data thus support the possibility that 
impulsivity might be a pre-existing trait, and this notion inspired our next experiment.    
Not all drug users become addicted.  It is estimated that only 10-15% of initial 
users ultimately become dependent (Gawin, 1991).  Based on statistics linking an initial 
responsiveness of a psychostimulant to the long-term rate of use and abuse, it is 
intriguing to think that one might be able to predict long-term deficits based on one 
single exposure.  We, and others (Sabeti et al., 2002; Sabeti et al., 2003; Gulley et al., 
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2003), have used the initial drug response to classify outbred, male, Sprague-Dawley 
rats based on the median split of locomotor activity for the first 30 minutes following an 
acute injection of a low dose of cocaine (10 mg/kg).  As reported in Chapter 3, rats were 
classified into LCRs and HCRs and then trained on a delay- discounting task.  Again, 
this task is extremely sensitive to rats’ inability to tolerate long delays for larger food 
reinforcement.  To our surprise, we found that HCRs were more impulsive than LCRs.  
The results were somewhat unexpected because previous studies have shown that 
LCRs are more sensitive to the discriminative stimulus properties of cocaine (Klein and 
Gulley, 2009), show conditioned place preference for cocaine (Allen et al., 2007), and 
self-administer cocaine more readily than HCRs (Mandt et al., 2008).  Taken together, 
those results suggest that LCRs are more vulnerable to the rewarding and reinforcing 
properties of cocaine.  Considering that DA is primarily important for the acute 
response, as the first injection of cocaine inhibits DAT-mediated clearance of DA and 
increases extracellular DA in the nucleus accumbens and dorsal striatum to a greater 
extent in HCRs than LCRs (Sabeti et al., 2002; Nelson et al., 2009), it is logical that 
HCRs behaved more impulsively.  Previous studies have shown that the depletion of 
DA or infusion of DA receptor antagonists in the ventral striatum profoundly reduced 
impulsivity (Cole and Robbins, 1989; Pattij et al., 2007; Pezze et al., 2007), which is in 
agreement with our findings in LCRs.  Hence, it is not surprising that LCRs and HCRs 
differed in impulsive behavior.   
A final set of experiments were conducted to determine: (1) if repeated AMPH 
exposure would produce more significant impairments in a task that, relative to delay-
discounting, has been shown consistently to be highly sensitive to changes in cortical 
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function (Fuster and Alexander, 1971; Kolb, 1990; Goldman-Rakic, 1995; Dias and 
Aggleton, 2000; Brown and Bowman, 2002); (2) if a model of repeated AMPH exposure 
that more closely approximates human patterns of drug intake would produce more 
significant cognitive impairments than are seen with an intermittent exposure model; (3) 
if the age of exposure contributes to AMPH’s ability to produce cognitive deficits, 
considering that adolescence is an important period of normal developmental flux; and 
(4) if subsequent cognitive function can be predicted based on an animal’s initial 
sensitivity to a psychostimulant during both adolescence and adulthood. 
We found an inverse relationship between the robustness of a sensitized 
locomotor response and ensuing cognitive deficits after repeated AMPH exposure.  
That is, while adolescent rats were less sensitive to the stereotypy-inducing effects of 
both an intermittent and escalation-binge method, they were more vulnerable to 
exposure-induced learning and memory impairments.  Current evidence suggests that 
the nature and timing of normal developmental changes interacts with the changes 
occurring in response to drug exposure (see Brenhouse and Andersen, 2011).  A long 
history of experience-dependent changes in the developing brain exists, including 
experiences with psychoactive drugs (Diaz Heijtz et al., 2003; Robinson and Kolb, 
2004), sensory and motor enrichments (Rosenzweig et al., 1962; Greenough and 
Chang, 1988; Kolb et al., 2003; Mychasiuk et al., 2012), parental-infant and peer 
relationships (Weaver et al., 2004; Bell et al., 2010), and stress (Andersen and Teicher, 
2008; Muhammad and Kolb, 2012).    
Optimal levels of DA are critical to proper function of the PFC (Arnsten and 
Pliszka, 2011).  One plausible mechanism then is that the normal developmental 
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process of overproduction and regressive elimination that fine tunes the brain for 
efficiency is dramatically altered in response to drug exposure.  Thus, overproduction 
and pruning of D1 receptors on glutamatergic output neurons during development (at 
PND40) could be responsible for the enduring changes (Brenhouse et al., 2008).  It is 
known that cortical development lags in children with ADHD (Shaw et al., 2007), but is 
accelerated in schizophrenia (Rapoport et al., 1999).  Nonetheless, a shift in the pruning 
response could lead to long-lasting changes, and such effects would agree with the 
“equal, but opposite” model of enduring drug action (Andersen, 2003, 2005).  Briefly, 
this model states that whatever long-term effects are produced during adulthood, the 
opposite effect will be true following drug administration during adolescence.  Thus, 
chronic exposure to a lower dose during adolescence has the potential to exacerbate 
symptoms later in adulthood.  In agreement then with the working hypothesis, adult-
exposed rats in the escalation-binge treatment group showed delay-dependent deficits 
that persisted through criterion, overtraining, and task reversal.  Because adolescent-
exposed rats showed improvements in memory function over time, unlike the adult-
exposed rats, we conclude that adults are more prone to the neurotoxic effects of high-
dose AMPH treatment.  Support of this notion comes from rats exposed to escalating 
dose-multiple binge exposure of methamphetamine (Kuczenski et al., 2007).   
Interestingly, the delay dependent deficits in adolescent- and adult-exposed rats 
were predicted based on their initial sensitivity to a single injection of cocaine.  In terms 
of locomotor responses after repeated exposure, however, the differences between 
LCRs and HCRs disappeared in parallel with the development of behavioral 
sensitization.  Because there are no pharmacokinetic differences after the acute drug 
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response (Gulley et al., 2003), it is unlikely that metabolic differences are responsible 
for the long-term changes.  To our knowledge, there are no reports of age-dependent 
differences in AMPH metabolism with repeated treatment regimens (see Cho et al., 
2001).  It should be noted that rats metabolize stimulants rapidly (half-life of 70 minutes 
versus 12 hours in humans), and consequently, drug pharmacokinetics need to be 
considered more so when interpreting data across species.  Therefore, one proposed 
mechanism to explain the memory deficits is an alteration of NMDA and AMPA 
receptors.  There are known differences between LCRs and HCRs in levels of these 
glutamate receptors following both acute and repeated psychostimulant exposure 
(Yamamoto and Zahniser, 2012).  Taken together with the documented role of NMDA 
and AMPA receptors in the role of working memory, (Rotaru et al., 2011; Arnsten et al., 
2012; Wang et al., 2013; Zhang et al., 2013), the LCR/HCR model becomes very 
attractive to further exploration.     
In summary, our data suggest that repeated AMPH has long-lasting 
consequences on learning and memory processes that persist well after drug exposure 
has ceased.  These deficits appeared to be closely associated with initial differences in 
cocaine-induced locomotor activity.  Importantly, these deficits were dependent on both 
the age and method of drug exposure.  While psychostimulants have a well-
documented ability to alter or reduce plasticity, higher escalating-binge doses might 
have the potential to change brain structure and function permanently.  With that in 
mind, perhaps clinicians should think twice before prescribing a young child a repetitive 
dosing regimen of AMPH, especially if a therapeutic advantage is unclear.  Without a 
doubt, more research is warranted to determine the individual persistence of damage 
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caused by both intermittent and escalating-binge exposures at vulnerable times of 
development and maturity.  Nonetheless, it is clear that a systems research approach 
will be necessary to examine the long-lasting course of dysfunction that is observed in 
adulthood. 
  
  
 109 
CHAPTER 7: FIGURES AND TABLES 
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Fig. 2.1.  Locomotor activity (ambulatory distance; A) or stereotypy rating (B) after 
acute AMPH or saline (Day 2), repeated AMPH or saline (Day 20), and the AMPH 
challenge given at the conclusion of the operant behavior phase of the study.  AMPH 
was always given at a dose of 3 mg/kg (i.p.).  Shown in the AMPH group are the data 
from 12 of 15 subjects tested because technical problems resulted in the loss of data 
from three subjects.  **p<.01, Day 2 compared to Day 20 within the AMPH group; 
##p<.01, between group comparison on Day 2; +++ p<.001, challenge compared to 
Day 2 and Day 20 within the SAL group; *** p<.001, challenge compared to Day 20 
within the AMPH group; ###p<.001, between group comparison on challenge 
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Fig. 2.2.  Choice behavior for rats in the saline (SAL; n=14) and AMPH (n=15) 
pretreatment groups for early acquisition (sessions 1-3; A), training midpoint 
(sessions 18-20; B), and at stable baseline (vehicle sessions 41, 44, and 47; C).   
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Fig. 2.3. The effects of AMPH (0.1-2.0 mg/kg) on delay-discounting behavior in rats 
pre-treated with saline or AMPH.  Shown are the mean choice of the large reward for 
the saline (SAL; A) and AMPH (B) pretreated groups across delays.  (C) Shown are 
the number of omissions as a function of delay for the SAL (open symbols) and 
AMPH (filled symbols) pre-treatment groups.  For enhanced presentation clarity, only 
the highest doses of AMPH are included.  *** p<.001, compared to vehicle at the 
same delays; ###p<.001, collapsed across delay   
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Fig. 2.4.  Dose-response curves showing the effects of AMPH (0.1-2.0 mg/kg) on (A) 
latency to nosepoke for the initiation of a trial (NP) and to choose a lever (LP), and 
(B) the total number of nosepoke responses during ITIs (B) and delays (C).  **p<.01 
and *** p<.001, compared to vehicle (V) 
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Fig. 3.1.  Locomotor activity (distance, in cm) after the first (Test 1) and second 
(Retest) injection with 10 mg/kg cocaine.  The retest occurred following the 
conclusion of the operant behavior phase of the study, with ~ 3 months separating the 
two tests.  Shown is a scatter plot of the cumulative locomotor activity (mean shown 
as a horizontal line) for the 30-min following i.p. injection.  The response during Test 1 
was used to classify rats as LCRs or HCRs (n = 8/group).  ### p < 0.001, compared 
to HCRs at Test1; ** p < 0.01, Test 1 compared to Retest within HCRs 
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Fig. 3.2.  Choice behavior during early acquisition (sessions 1-3; A), training midpoint 
(sessions 15-17; B), and at stable baseline (vehicle sessions 35, 37, and 39; C) for 
rats classified as LCRs or HCRs (n = 8/group).  Shown is the mean choice of the 
large reward ( SEM) at each delay during the three sessions that were within these 
training time periods.  ** p < 0.01 and *** p < 0.001, compared to 0 s; # p < 0.05 and 
## p < 0.01, compared to HCRs at the indicated time points 
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  Fig. 3.3.  The effects of AMPH (0.3-1.0 mg/kg) on delay-discounting behavior in LCRs 
and HCRs (n = 8/group).  Shown in A and B is the mean choice of the large reward ( 
SEM) across delays for LCRs (A) and HCRs (B).  Vehicle injection data are the same 
as that shown in Fig. 2C.  The mean number of trial omissions ( SEM) as a function of 
delay is shown in C.  Only the 1.0 mg/kg dose of AMPH is shown because there were 
no significant increases in omissions at 0.3 or 0.6 mg/kg.  ** p < 0.01, compared to 
vehicle at the 20-s delay; ## p < 0.01, compared to vehicle at the 20-s delay for HCRs 
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Fig. 3.4.  The effects of 8-OH-DPAT (0.3-1.0 mg/kg) on delay-discounting behavior in LCRs 
or HCRs (n = 8/group).  Shown in A and B is the mean choice of the large reward ( SEM) 
across delays for LCRs (A) and HCRs (B).  The mean number of trial omissions ( SEM) as 
a function of delay is shown in C.  The 0.3 mg/kg dose is not shown because it did not 
significantly increase trial omissions at any of the delays.  For A: * p < 0.05, comparison 
between 0.6 mg/kg and vehicle at the indicated delay; # p < 0.05, comparison between 1.0 
mg/kg and vehicle at the indicated delay; For B: **p<.01 and *** p<.001, compared to vehicle 
at the 0-s delay.  For C: * p < 0.05, comparison between 0.6 mg/kg and vehicle at the 
indicated delay for HCRs; # p < 0.05, comparison between 1.0 mg/kg and vehicle at the 
indicated delay for HCRs 
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Table 3.1.  Mean latencies (s) to nosepoke for the initiation of a trial and to choose a lever, following injection of 
vehicle, AMPH or 8-OH- DPAT. SEM is given in parentheses.  ** p<0.01 and *** p<0.001, compared to vehicle 
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Fig. 4.1.  Locomotor activity (distance, in cm) after the initial injection with 10 mg/kg 
cocaine in adolescent rats (PND35) and adult (PND90) rats.  This response was used 
to classify rats as LCRs or HCRs. 
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Fig. 4.2.  Locomotor activity (ambulatory distance, in cm; A) and stereotypy rating (B) 
during the first (T1) and tenth (T10) injection of saline or AMPH and after a challenge 
with AMPH at the conclusion of operant testing for all rats.  AMPH was always 
administered at a dose of 3 mg/kg (i.p.).  **p<0.01 and ***p<0.001, compared to age-
group controls within treatment session; +p<0.05, ++p<0.01, +++p<0.001, compared to 
previous session within group; #p<0.05, ###p<0.001, between-group comparisons 
within session 
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Fig. 4.3.  Locomotor activity (ambulatory distance, in cm) during a post-escalation binge 
episode (8 hours) of saline or AMPH.  Each injection (every 2 hours) is denoted by the 
vertical dotted lines.  AMPH was always administered at a dose of 8 mg/kg (i.p.). 
+++p<0.001, compared to last 15 min bin of each 2-hr injection period within 
adolescent-exposed group; #p<0.05, ##p<0.01, ###p<0.001, between-group 
comparison 
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Fig. 4.4.  Locomotor activity (ambulatory distance, in cm; A) and stereotypy rating (B) 
during the challenge session following post-escalation and binge and after a challenge 
with AMPH at the conclusion of operant testing for all adolescent- and adult-exposed 
rats.  AMPH was always administered at a dose of 8 mg/kg (i.p.). +++p<0.001, 
compared to previous session within group; #p<0.05, ##p<0.01, ###p<0.001, between-
group comparisons within challenge session 
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Fig. 4.5.  Task criterion behavior for each delay block of the matching and non-
matching (reversal) components for adolescent-exposed (A) and adult-exposed 
(B) rats.  Data are shown as the mean number of sessions to reach ≥85% 
performance for two consecutive sessions. *p<0.05 and **p<0.01, compared to 
controls within delay block; #p<0.05, ##p<0.01, ###p<0.001, between-age group 
compared to same treatment group  
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Fig. 4.6.  Performance accuracy, shown as mean percent correct for treatment 
groups across delays, during two different phases of the long delay block (first 
two sessions: A and B; at criterion: C, D) for adolescent-exposed (A, C) and 
adult-exposed rats (B, D). *p<0.05, **p<0.01, and ***p<0.001 compared to saline 
controls within delay. 
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Fig. 4.7.  Performance accuracy, shown as mean percent correct for treatment 
groups across delays, during two first two sessions of the long delay block for 
animals classified by their cocaine response (LCRs: A and B; HCRs: C, D) for 
adolescent-exposed (A, C) and adult-exposed rats (B, D). *p<0.05, **p<0.01, and 
***p<0.001 compared to saline controls within delay. 
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 Time 
Day 8:30 am 2:00 pm 7:30 pm 
1 1 mg/kg 2 mg/kg 3 mg/kg 
2 3 mg/kg 4 mg/kg 5 mg/kg 
3 5 mg/kg 6 mg/kg 7 mg/kg 
4 7 mg/kg 8 mg/kg  
5 Day off 
6 8 mg/kg (x 4, once every 2 hours) 
 
Table 4.1. Treatment schedule for escalation-binge 
exposure to AMPH.  Adapted from Segal and 
Kuczenski, 1997 
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Fig. 5.1. Schematic diagram of recording site locations in the ventral mPFC.  Dots 
represent the approximate locations of electrode microwire bundles from each rat that 
were histologically verified to terminate in the prelimbic and infralimbic regions.  The 
filled dots correspond to the AMPH-treated rats (n=5), while the open dots correspond 
to the saline-treated rats (n=4).  These coronal section images were adapted from the 
stereotaxic atlas of Paxinos and Watson (1998).  
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Fig. 5.2. Mean number of quadrant crossings in the open-field arena for the 45 min 
period after the first (T1) or fifth (T5) treatment and after challenge injections (Ch 1 and 
Ch 2) given following 3 days without treatment. Rats in the AMPH group (n = 5) 
received 1 mg/kg AMPH during tests 1 and 5 and during Ch 2; they received saline 
during Ch 1. Rats in the saline group (n = 4) received saline during all sessions. **p < 
0.01, vs. saline group within-session; #p < 0.05, vs. AMPH group pre-test; @p < 0.05, 
vs. AMPH group during T1 
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Fig. 5.3. Analysis of single-unit data recorded from microwire electrodes implanted in 
the rat mPFC.  (A) 2-D scatter plot of PCA for the signal measured on one channel of a 
16-channel electrode bundle.  Spikes from a given neuron appear as a cluster of points, 
usually separated from other clusters.  Cluster boundaries (represented by the dotted 
lines) are defined interactively during data analysis.  (B) Waveform profiles from 
putative pyramidal cells recorded over the course of the experiment.  ‘Unit a’ was 
recorded on first test day, while ‘Unit b’ was recorded 9 days later during challenge 2.  
Autocorrelation histograms, which are used as part of the procedure to classify single-
unit activity, are also shown for these units.  (C,D) Firing rate histograms from two 
different units during baseline recording and after an injection of 1 mg/kg AMPH (at 
arrow).  The cell shown on top was classified as having a decreased firing rate in 
response to AMPH, whereas the cell on the bottom was classified as increased.   
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Fig. 5.4. Responses of mPFC neurons to saline and AMPH across treatment (T) and 
challenge (Ch) sessions. (A) Units were characterized as increased or decreased if mean 
firing rate was consistently above or below, respectively, the baseline firing rate during the 5-
min period before injection (see Experimental Procedures for analysis details). **p < 0.001, 
χ2 statistic comparing proportion of responses in AMPH and saline groups; #p < 0.001, χ2 
statistic comparing proportion of responses in AMPH group on Ch 1 and T1 (B) Firing rate, 
normalized to pre-injection baseline, during the 45-min period following saline or AMPH in 
units exhibiting a sustained decrease (-), increase (+), or no consistent change (NC). *p < 
0.05 and ***p < 0.001, compared to units increasing firing rate following AMPH injection #p < 
0.05 and ###p < 0.001, compared to units with no consistent change (NC) after AMPH 
injection; @p < 0.05, compared to firing rate during T1 for the same category of responses 
following the same injection type 
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Fig. 5.5. Burst rate and percent of spikes in bursts for mPFC neurons recorded before and 
after injection with saline or AMPH during treatment (T) and challenge (Ch) sessions. In (A) 
and (C), data are presented for the baseline (B) and post-injection (P) periods. In (B) and 
(D), burst rate and % of spikes in bursts, respectively, are normalized to the pre-injection 
baseline for each unit. ###p < 0.001, AMPH group compared to T1; *p < 0.05 and **p < 0.01, 
compared to saline group 
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   Firing rate (spikes/s)  Burst rate (bursts/min) 
 Saline AMPH  Saline AMPH 
Treatment 1      
(n) (43) (61)    
active 0.609 ± 
0.136 
0.605 ± 
0.080 
 2.02 ±1.04 2.01 ± 
0.44 
inactive 0.650 ± 
0.129 
0.636 ± 
0.067 
 2.01 ± 
0.88 
2.16 ± 
0.31 
Treatment 5      
(n) (39) (45)    
active 1.12 ± 
0.060 
0.907 ± 
0.142 
 3.47 ± 
1.52  
3.65 ± 
0.97 
inactive 1.44 ± 
0.060* 
0.769 ± 
0.106 
 5.28 ± 
1.80* 
2.96 ± 
0.63 
Challenge 1      
(n) (34) (46)    
active 0.659 ± 
0.195 
0.523 ± 
0.079 
 2.61 ± 
1.07 
1.77 ± 
0.43 
inactive 0.644 ± 
0.183 
0.566 ± 
0.062 
 2.47 ± 
1.02 
1.79 ± 
0.36 
Challenge 2      
(n) (39) (42)    
active 0.709 ± 
0.155 
0.448 ± 
0.051 
 3.30 ± 
0.96 
1.15 ± 
0.23 
inactive 0.847 ± 
0.163 
0.498 ± 
0.050 
 3.46 ± 
0.86 
1.32 ± 
0.25 
 
Table 5.1. Mean (± SEM) firing and burst rates for mPFC neurons recorded 30 min 
prior to injection with saline or AMPH on treatment days 1 and 5 and challenge 
days 1 and 2. Data are presented for the first and second 15-min periods that rats 
where in the open-field arena, which encompassed periods of high (“active”) and 
low (“inactive”) spontaneous motor activity, respectively. The number of cells 
recorded during each of the sessions (n) is shown in the firing rate columns.  *p < 
0.05, compared to active baseline 
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